812 Biomarkers
| ID | Biomarker | Location | Application | Reference |
|---|---|---|---|---|
| 1 | P53 | Colon, Rectum | Prognosis | Yamaguchi A et al. Cancer. 1992 |
| 2 | MYC-1 | Colon, Rectum | Prognosis | Yamaguchi A et al. Oncology. 1992 |
| 3 | CA242 | Colon, Rectum | Diagnosis | Nilsson O et al. Br J Cancer. 1992 |
| 4 | Sialosyl-Tn | Colon | Prognosis | Itzkowitz SH et al. Cancer. 1990 |
| 5 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Davey P et al. Eur J Surg Oncol. 1987 |
| 6 | Sialomucin | Colon, Rectum | Prognosis | Dawson PM et al. Int Surg. 1987 |
| 7 | Alkaline phosphatase (AP) | Colon, Rectum | Prognosis | Aabo K et al. Eur J Cancer Clin Oncol. 1986 |
| 8 | Tissue polypeptide-specific antigen (TPS) | Colon, Rectum | Diagnosis | Kornek G et al. Br J Cancer. 1995 |
| 9 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Miles WF et al. Br J Gen Pract. 1995 |
| 10 | Tumour-associated trypsin inhibitor (TATI) | Colon, Rectum | Diagnosis | Pasanen P et al. Scand J Clin Lab Invest. 1995 |
| 11 | Sialyl Lewis(a) antigen(SLA) | Colon, Rectum | Prognosis | Nakayama T et al. Cancer. 1995 |
| 12 | Urokinase-type plasminogen activator (uPA) | Colon, Rectum | Prognosis | Sato T et al. Oncology. 1995 |
| 13 | IGF-1 receptors (IGF-1R) | Colon, Rectum | Prognosis | Bhatavdekar JM et al. Eur J Surg Oncol. 1995 |
| 14 | C-erbB-2 | Colon, Rectum | Prognosis | Kay EW et al. Histopathology. 1994 |
| 15 | CA 19.9 | Colon, Rectum | Prognosis | Diez M et al. Anticancer Res. 1994 |
| 16 | E-cadherin | Colon, Rectum | Prognosis | Dorudi S et al. Br J Cancer. 1995 |
| 17 | Proliferating cell nuclear antigen (PCNA) | Colon, Rectum | Treatment | Willett CG et al. J Clin Oncol. 1994 |
| 18 | Carbohydrate antigen 19-9 (CA19-9) | Colon, Rectum | Prognosis | Ueda T et al. Surg Today. 1994 |
| 19 | P53 | Colon, Rectum | Prognosis | Zeng ZS et al. J Clin Oncol. 1994 |
| 21 | S-aspartate aminotransferase (S-ASAT) | Colon, Rectum | Prognosis | Graf W et al. Eur J Cancer. 1994 |
| 22 | Gp78 | Colon, Rectum | Prognosis | Nakamori S et al. Cancer. 1994 |
| 23 | Proliferating cell nuclear antigen (PCNA) | Colon, Rectum | Prognosis | al-Sheneber IF et al. Cancer. 1993 |
| 24 | Sialyl Lex antigen | Colon, Rectum | Prognosis | Nakagoe T et al. Cancer. 1993 |
| 25 | Prostaglandin E2 (PGE2) | Colon, Rectum | Prognosis | Oka M et al. Am J Surg. 1994 |
| 26 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Wang JY et al. Dis Colon Rectum. 1994 |
| 27 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Zeng Z et al. Dis Colon Rectum. 1993 |
| 28 | Prolactin (PRL) | Colon, Rectum | Prognosis | Patel DD et al. Cancer. 1994 |
| 29 | Helix pomatia agglutinin | Colon, Rectum | Prognosis | Ikeda Y et al. Dis Colon Rectum. 1994 |
| 31 | P53 | Colon, Rectum | Prognosis | Yamaguchi A et al. Br J Cancer. 1993 |
| 32 | NCC-ST-439 (ST439) | Colon, Rectum | Diagnosis | Iemura K et al. Eur J Surg Oncol. 1993 |
| 33 | Urokinase-type plasminogen activator (uPA) | Colon, Rectum | Diagnosis | Huber K et al. Cancer Res. 1993 |
| 34 | Gastrin | Colon, Rectum | Prognosis | Kameyama M et al. Dis Colon Rectum. 1993 |
| 35 | Small Intestinal Mucin Antigen (SIMA) | Colon, Rectum | Diagnosis | Pinczower GD et al. Int J Cancer. 1993 |
| 36 | CD44v | Colon, Rectum | Diagnosis | Suh SI et al.J Korean Med Sci. 1995 |
| 37 | CD44v8-10 | Colon, Rectum | Prognosis | Yamaguchi A et al. J Clin Oncol. 1996 |
| 38 | CEA, CA242 | Colon, Rectum | Diagnosis | Carpelan-Holmström MA et al. Dis Colon Rectum. 1996 |
| 39 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Girard P et al. J Clin Oncol. 1996 |
| 40 | TAG-72 | Colon, Rectum | Diagnosis | Guadagni F et al. Anticancer Res. 1996 |
| 41 | CA 242, CEA | Colon, Rectum | Prognosis | Carpelan-Holmström M et al. Eur J Cancer. 1996 |
| 42 | P53 | Colon, Rectum | Prognosis | Belluco C et al. J Clin Oncol. 1996 |
| 43 | CD44 v6 | Colon, Rectum | Prognosis | Nihei Z et al. Surg Today. 1996 |
| 44 | Alpha 1-acid glycoprotein (AAG), CA 19-9 | Colon, Rectum | Prognosis | Yüceyar S et al. Int Surg. 1996 |
| 45 | DCC (deleted in colorectal cancer) | Colon, Rectum | Prognosis | Shibata D et al. N Engl J Med. 1996 |
| 46 | Matrix metalloproteinase-9 (MMP-9) | Colon, Rectum | Prognosis | Zeng ZS et al. J Clin Oncol. 1996 |
| 47 | Fecal CA II | Colon, Rectum | Diagnosis | Yokoyama S et al. Am Surg. 1997 |
| 48 | KRAS | Colon, Rectum | Prognosis | Lee JC et al. Anticancer Res. 1996 |
| 49 | CD44 | Colon | Diagnosis | Wong LS et al. Br J Surg. 1997 |
| 50 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Tobaruela E et al. Int J Biol Markers. 1997 |
| 51 | Nm23-H1 | Colon, Rectum | Prognosis | Tannapfel A et al. Am J Gastroenterol. 1997 |
| 52 | Tenascin | Colon, Rectum | Prognosis | Kressner U et al. Br J Cancer. 1997 |
| 54 | CA19-9 | Colon, Rectum | Prognosis | Nakayama T et al. J Surg Oncol. 1997 |
| 55 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Fujisaki K et al. Am J Gastroenterol. 1998 |
| 56 | C-myc | Colon, Rectum | Prognosis | Kakisako K et al. Oncol Rep. 1998 |
| 58 | CD44 variant 6 (CD44v6) | Colon, Rectum | Prognosis | Wielenga VJ et al. Scand J Gastroenterol. 1998 |
| 60 | CD44 | Colon, Rectum | Prognosis | Ropponen KM et al. Scand J Gastroenterol. 1998 |
| 61 | KRAS | Colon, Rectum | Prognosis | Cerottini JP et al. Am J Surg. 1998 |
| 62 | D-dimer (DD) | Colon, Rectum | Diagnosis | Oya M et al. Surg Today. 1998 |
| 63 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Diagnosis | Kumar H et al. Clin Cancer Res. 1998 |
| 65 | Alpha-Catenin | Colon, Rectum | Prognosis | Raftopoulos I et al. J Surg Oncol. 1998 |
| 66 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Forones NM et al. Sao Paulo Med J. 1997 |
| 67 | Deleted in colorectal cancer (DCC) | Colon, Rectum | Prognosis | Reymond MA et al. Dis Colon Rectum. 1998 |
| 68 | CD44v8-10 | Colon, Rectum | Prognosis | Yamaguchi A et al. J Gastroenterol. 1998 |
| 69 | TP53, K-ras | Colon, Rectum | Prognosis | Hardingham JE et al. Gut. 1998 |
| 70 | HLA-DR antigen, Proliferating cell nuclear antigen labeling index (PCNA-LI) | Colon, Rectum | Prognosis | Kunihiro M et al. Oncology. 1998 |
| 71 | Tissue polypeptide-specific antigen (TPS) | Colon, Rectum | Prognosis | Mishaeli M et al. Anticancer Res. 1998 |
| 73 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Leichman CG et al. Oncology (Williston Park). 1998 |
| 74 | CD44v8-10, Sialyl LeX (SLX) | Colon, Rectum | Prognosis | Yamaguchi A et al. Oncology. 1998 |
| 75 | CD44 | Colon, Rectum | Prognosis | Bhatavdekar JM et al. Ann Surg Oncol. 1998 |
| 76 | C-erbB-2 | Colon, Rectum | Prognosis | Osako T et al. Oncology. 1998 |
| 77 | Interleukin-2 (IL-2R) | Colon, Rectum | Prognosis | Saito H et al. Surg Today. 1998 |
| 78 | P53 | Colon, Rectum | Prognosis | Nitti D et al. Eur J Cancer. 1998 |
| 79 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Nozoe T et al. Am J Surg. 1998 |
| 80 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Chapman MA et al. Br J Cancer. 1998 |
| 81 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Ishigami SI et al. Br J Cancer. 1998 |
| 82 | Bcl-2 | Colon, Rectum | Prognosis | Ilyas M et al. Gut. 1998 |
| 83 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis, Prognosis | Li Destri G et al. Surg Today. 1998 |
| 84 | Soluble interleukin-2 receptor (sIL-2R) | Colon, Rectum | Prognosis | Shibata M et al. Oncology. 1999 |
| 85 | NCC-ST-439 (ST439) | Colon, Rectum | Prognosis | Matsumoto K et al. Surg Today. 1999 |
| 86 | DCC gene | Colon, Rectum | Prognosis | Saito M et al. Oncology. 1999 |
| 87 | P27 (Kip1) | Colon, Rectum | Prognosis, Treatment | Belluco C et al. Ann Surg Oncol. 1999 |
| 88 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis, Treatment | Hyodo I et al. Eur J Cancer. 1998 |
| 90 | High mobility group I(Y) [HMGI(Y)] | Colon, Rectum | Diagnosis, Prognosis | Abe N et al. Cancer Res. 1999 |
| 91 | Soluble CD44 splice variants containing exon v6 (sCD44v6) | Colon, Rectum | Prognosis | Yamane N et al. Oncology. 1999 |
| 92 | Bax | Colon, Rectum | Prognosis | Sturm I et al. J Clin Oncol. 1999 |
| 93 | CA 242 | Colon, Rectum | Diagnosis | Spila A et al. Anticancer Res. 1999 |
| 94 | Sialyl Lewis X (SLX) | Colon, Rectum | Prognosis | Tanaka K et al. Hepatogastroenterology. 1999 |
| 95 | P27 (Kip1) | Colon, Rectum | Prognosis | Palmqvist R et al. J Pathol. 1999 |
| 96 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Carriquiry LA et al. Dis Colon Rectum. 1999 |
| 98 | P53 | Rectum | Treatment | Adell G et al. Radiother Oncol. 1999 |
| 100 | NuMA | Colon, Rectum | Diagnosis | Briggman J et al. Anticancer Res. 1999 |
| 101 | P21 | Colon, Rectum | Prognosis | Ropponen KM et al. Br J Cancer. 1999 |
| 102 | Liver fatty acid-binding protein (L-FABP) | Colon, Rectum | Prognosis | Yamazaki T et al. J Surg Oncol. 1999 |
| 103 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Aschele C et al. J Clin Oncol. 1999 |
| 105 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Treatment | Dawson LA et al. Cancer J Sci Am. 1999 |
| 106 | CD44v2 | Colon, Rectum | Treatment | Haruyama K et al. Anticancer Res. 1999 |
| 107 | P53, Bcl-2 | Rectum | Prognosis | Schwandner O et al. Eur J Cancer. 2000 |
| 108 | Interleukin-6 (IL-6) | Colon, Rectum | Prognosis | Belluco C et al. Ann Surg Oncol. 2000 |
| 109 | Anti-survivin antibodies | Colon, Rectum | Diagnosis | Rohayem J et al. Cancer Res. 2000 |
| 110 | CD44 | Colon, Rectum | Prognosis | Tachikawa D et al. Anticancer Res. 2000 |
| 111 | P21 | Colon, Rectum | Treatment | Qiu H et al. Dis Colon Rectum. 2000 |
| 112 | Metalloproteinases (MMPs) | Colon, Rectum | Prognosis | Sunami E et al. Oncologist. 2000 |
| 113 | CDC25B | Colon, Rectum | Prognosis, Treatment | Takemasa I et al. Cancer Res. 2000 |
| 114 | P53 | Colon, Rectum | Prognosis, Treatment | Bouzourene H et al. Eur J Cancer. 2000 |
| 115 | Telomerase | Colon, Rectum | Prognosis | Tatsumoto N et al. Clin Cancer Res. 2000 |
| 116 | Antigens A, B, H | Colon, Rectum | Prognosis | Nakagoe T et al. J Cancer Res Clin Oncol. 2000 |
| 117 | Glutathione | Colon, Rectum | Prognosis | Barranco SC et al. Dis Colon Rectum. 2000 |
| 118 | Insulin-like growth factor I (IGF-I) | Colon, Rectum | Diagnosis | Renehan AG et al. J Clin Endocrinol Metab. 2000 |
| 120 | Endothelin-1 (ET-1) | Colon, Rectum | Diagnosis | Simpson RA et al. Br J Surg. 2000 |
| 121 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Treatment | Chin KF et al. Br J Cancer. 2000 |
| 122 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Werther K et al. Eur J Surg Oncol. 2000 |
| 123 | Hyaluronic acid (HA) | Colon, Rectum | Prognosis | Llaneza A et al. Br J Surg. 2000 |
| 124 | Interleukin-12 (IL-12) | Colon, Rectum | Diagnosis | Nakayama Y et al. Anticancer Res. 2000 |
| 125 | P53 autoantibodies | Colon, Rectum | Prognosis | Takeda A et al. Eur J Surg. 2001 |
| 126 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Broll R et al. Eur J Surg Oncol. 2001 |
| 127 | Ki-67 | Colon, Rectum | Prognosis | Petrowsky H et al. Eur J Surg Oncol. 2001 |
| 128 | c-Myb, Bcl-x | Colon, Rectum | Prognosis | Biroccio A et al. Am J Pathol. 2001 |
| 130 | Bax | Colon, Rectum | Prognosis | Giatromanolaki A et al. Anticancer Res. 2001 |
| 132 | Carcinoembryonic gene member 2 (CGM2) | Colon, Rectum | Diagnosis | Douard R et al. Surgery. 2001 |
| 133 | Transforming growth factor-beta1(TGFbeta1) | Colon, Rectum | Diagnosis | Tsushima H et al. Clin Cancer Res. 2001 |
| 134 | Ki-67 | Colon, Rectum | Treatment | Adell G et al. Int J Radiat Oncol Biol Phys. 2001 |
| 135 | Angiomodulin (tumor-derived adhesion factor/mac25) | Colon, Rectum | Prognosis | Adachi Y et al. Int J Cancer. 2001 |
| 137 | Cytokeratin 19, 20 | Colon, Rectum | Prognosis | Fujita S et al. Int J Colorectal Dis. 2001 |
| 138 | Matrilysin | Colon, Rectum | Prognosis | Adachi Y et al. Int J Cancer. 2001 |
| 139 | Faecal calprotectin | Colon, Rectum | Diagnosis | Tibble J et al. Gut. 2001 |
| 140 | Metallothionein (MT) | Colon, Rectum | Prognosis | Hishikawa Y et al. Oncology. 2001 |
| 141 | Matrix metallproteinases (MMP)-2, -9 | Colon, Rectum | Diagnosis | Okada N et al. Biochem Biophys Res Commun. 2001 |
| 142 | Pyrimidine nucleoside phosphorylase (PyNPase) | Colon, Rectum | Prognosis | Osanai T et al. Jpn J Clin Oncol. 2001 |
| 143 | P53 antibody | Colon, Rectum | Diagnosis | Takeda A et al. Int J Clin Oncol. 2001 |
| 144 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Nakagoe T et al. Anticancer Res. 2001 |
| 145 | Beta-catenin | Colon, Rectum | Prognosis | Chung GG et al. Clin Cancer Res. 2001 |
| 146 | Bcl-2 | Rectum | Treatment | Scopa CD et al. Appl Immunohistochem Mol Morphol. 2001 |
| 147 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Prognosis | Yamauchi T et al. Dis Colon Rectum. 2002 |
| 148 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon | Diagnosis | Holten-Andersen MN et al. Clin Cancer Res. 2002 |
| 150 | PGP9.5 | Colon, Rectum | Diagnosis | Yamazaki T et al. Clin Cancer Res. 2002 |
| 151 | Granulocyte-macrophage-colony stimulating factor (GM-CSF) | Colon, Rectum | Diagnosis | Mroczko B et al. Folia Histochem Cytobiol. 2001 |
| 152 | KAI1/CD82 | Colon, Rectum | Prognosis | Muneyuki T et al. Anticancer Res. 2001 |
| 153 | Fibronectin receptor (FnR, alpha5beta1 integrin) | Colon, Rectum | Treatment | Jayne DG et al. Eur J Surg Oncol. 2002 |
| 155 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Werther K et al. Br J Cancer. 2002 |
| 156 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis, Treatment | Edler D et al. J Clin Oncol. 2002 |
| 157 | Carbohydrate antigen 19-9 (CA19-9) | Colon, Rectum | Prognosis | Wang WS et al. Hepatogastroenterology. 2002 |
| 158 | Intercellular adhesion molecule-1 (ICAM-1) | Colon, Rectum | Prognosis | Maeda K et al. Oncol Rep. 2002 |
| 159 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis, Treatment | Wang WS et al. Hepatogastroenterology. 2002 |
| 160 | Von Willebrand factor (vWF) | Colon, Rectum | Prognosis | Damin DC et al. Int J Colorectal Dis. 2002 |
| 161 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Kornmann M et al. J Gastrointest Surg. 2002 |
| 162 | Cytokeratin 20 (CK20) | Colon, Rectum | Diagnosis | Vlems FA et al. Mol Pathol. 2002 |
| 163 | Transforming growth factor-beta1(TGFbeta1) | Colon, Rectum | Diagnosis | Xiong B et al. World J Gastroenterol. 2002 |
| 164 | Macrophagecolony stimulating factor (M-CSF) | Colon, Rectum | Diagnosis | Mroczko B et al. Clin Chem Lab Med. 2002 |
| 165 | Metallothionein (MT) | Colon, Rectum | Prognosis | Janssen AM et al. Clin Cancer Res. 2002 |
| 168 | Angiogenin (ANG) | Colon, Rectum | Prognosis | Shimoyama S et al. Anticancer Res. 2002 |
| 169 | Cystatin-like metastasis-associated protein (CMAP) | Colon, Rectum | Prognosis | Utsunomiya T et al. Clin Cancer Res. 2002 |
| 170 | Transforming growth factor-beta1(TGFbeta1) | Colon, Rectum | Prognosis | Xiong B et al. World J Gastroenterol. 2002 |
| 171 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Nakayama Y et al. Anticancer Res. 2002 |
| 173 | C-erbB | Colon, Rectum | Prognosis | Knösel T et al. Clin Exp Metastasis. 2002 |
| 174 | Infiltrative growth (INF) | Colon, Rectum | Prognosis | Yamaguchi J et al. World J Surg. 2002 |
| 175 | SMAD4 | Colon, Rectum | Treatment | Boulay JL et al. Br J Cancer. 2002 |
| 176 | Survivin | Colon, Rectum | Prognosis, Treatment | Rödel F et al. Strahlenther Onkol. 2002 |
| 177 | Peripheral benzodiazepine receptor (PBR) | Colon, Rectum | Prognosis | Maaser K et al. Clin Cancer Res. 2002 |
| 178 | Thymidine phosphorylase (TP) | Colon, Rectum | Prognosis | Aoki T et al. Oncol Rep. 2002 |
| 179 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Sugiyama Y et al. Anticancer Drugs. 2002 |
| 180 | Decoy receptor 3 (DcR3) | Colon, Rectum | Treatment | Mild G et al. Int J Cancer. 2002 |
| 181 | Calcium-binding protein S100A4 | Colon, Rectum | Prognosis | Gongoll S et al. Gastroenterology. 2002 |
| 182 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Prognosis | Konno H et al. Clin Exp Metastasis. 2002 |
| 183 | Cathepsin D (CD) | Colon, Rectum | Prognosis | Kanber Y et al. Int J Biol Markers. 2002 |
| 184 | Alpha-L-fucosidase (AFU) | Colon, Rectum | Prognosis | Ayude D et al. Oncology. 2003 |
| 185 | Epidermal growth factor receptor (EGFR) | Colon, Rectum | Treatment | Giralt J et al. Int J Radiat Oncol Biol Phys. 2002 |
| 186 | KRAS2 | Colon, Rectum | Diagnosis, Prognosis | Ryan BM et al. Gut. 2003 |
| 187 | Endothelin-1 (ET-1) | Colon, Rectum | Diagnosis | Arun C et al. Int J Biol Markers. 2002 |
| 188 | Soluble tetranectin (TN) | Colon, Rectum | Prognosis | Høgdall CK et al. APMIS. 2002 |
| 189 | KAI1 | Colon, Rectum | Prognosis | Yang JL et al. Anticancer Res. 2002 |
| 190 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Gonen M et al. J Clin Oncol. 2003 |
| 191 | SMAD7 | Colon, Rectum | Prognosis | Boulay JL et al. Int J Cancer. 2003 |
| 192 | Alkaline phosphatase (AP), Performance status (PS) | Colon, Rectum | Prognosis | Yuste AL et al. Clin Colorectal Cancer. 2003 |
| 193 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Kawakami M et al. Surgery. 2003 |
| 194 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Seifert JK et al. Int J Surg Investig. 2000 |
| 195 | Tumor necrosis factor receptor type 1 (TNFR1) | Colon, Rectum | Prognosis | Yoshimura H et al. Anticancer Res. 2003 |
| 196 | c-MET | Colon, Rectum | Prognosis | Takeuchi H et al. Clin Cancer Res. 2003 |
| 197 | Polo-like kinase 1 (PLK1) | Colon, Rectum | Prognosis | Takahashi T et al. Cancer Sci. 2003 |
| 198 | Methylenetetrahydrofolate reductase (MTHFR) | Colon, Rectum | Treatment | Cohen V et al. Clin Cancer Res. 2003 |
| 199 | CD105 | Colon, Rectum | Prognosis | Li C et al. Br J Cancer. 2003 |
| 200 | CD55 | Colon, Rectum | Prognosis | Durrant LG et al. Cancer Immunol Immunother. 2003 |
| 202 | P53 | Colon, Rectum | Prognosis | Lashner BA et al. Am J Gastroenterol. 2003 |
| 203 | Tumor M2 Pyruvate Kinase (Tumor M2-PK) | Colon, Rectum | Diagnosis | Hardt PD et al. Anticancer Res. 2003 |
| 204 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Miura M et al. Anticancer Res. 2003 |
| 206 | CA19-9 | Colon, Rectum | Diagnosis, Prognosis | Nakagoe T et al. Hepatogastroenterology. 2003 |
| 207 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis, Treatment | Lissoni P et al. Int J Biol Markers. 2003 |
| 208 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Sawabata N et al. Ann Thorac Surg. 2003 |
| 209 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Diagnosis | Marchena J et al. Hepatogastroenterology. 2003 |
| 210 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Abe N et al. Oncol Rep. 2008 |
| 211 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Chin KF et al. Eur J Surg Oncol. 2003 |
| 212 | Thioredoxin-1 | Colon, Rectum | Prognosis | Raffel J et al. J Lab Clin Med. 2003 |
| 213 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Sakamoto J et al. Oncol Rep. 2003 |
| 214 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Higashiyama M et al. Jpn J Thorac Cardiovasc Surg. 2003 |
| 216 | Cyclooxygenase 2 (COX-2) | Colon, Rectum | Prognosis | Buecher B et al. Aliment Pharmacol Ther. 2003 |
| 217 | MMP-2, MMP-9 | Colon, Rectum | Prognosis | Tutton MG et al. Int J Cancer. 2003 |
| 218 | Epidermal growth factor | Colon, Rectum | Prognosis | Kopp R et al. Dis Colon Rectum. 2003 |
| 219 | Leptin | Colon, Rectum | Diagnosis | Stattin P et al. Oncol Rep. 2003 |
| 220 | CA 242, CEA | Colon, Rectum | Diagnosis, Prognosis | Kim SB et al. Int J Biol Markers. 2003 |
| 221 | Cyclin-dependent kinase 4 (CDK4), p16 | Colon, Rectum | Prognosis | Zhao P et al. World J Gastroenterol. 2003 |
| 223 | Decay-accelerating factor (DAF) | Colon, Rectum | Diagnosis | Mizuno M et al. Am J Gastroenterol. 2003 |
| 224 | Laminin 5 | Colon, Rectum | Diagnosis | Lenander C et al. Mol Pathol. 2003 |
| 225 | Beta-catenin | Colon, Rectum | Diagnosis, Prognosis | Wong SC et al. Mol Pathol. 2003 |
| 226 | 17beta-hydroxysteroid dehydrogenase (17HSD) | Colon, Rectum | Prognosis | Oduwole OO et al. J Steroid Biochem Mol Biol. 2003 |
| 227 | Tumour-associated trypsin inhibitor (TATI) | Colon, Rectum | Diagnosis | Solakidi S et al. Clin Biochem. 2004 |
| 228 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon, Rectum | Prognosis | Holten-Andersen M et al. Eur J Cancer. 2004 |
| 229 | Endothelin-1 (ET-1) | Colon, Rectum | Prognosis | Elahi MM et al. Asian J Surg. 2004 |
| 230 | Cyclooxygenase 2 (COX-2) | Colon, Rectum | Prognosis | Knösel T et al. Dis Colon Rectum. 2004 |
| 231 | Dihydropyrimidine dehydroganase (DPD) | Colon, Rectum | Prognosis, Treatment | Tsuji T et al. Cancer Lett. 2004 |
| 232 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Werther K et al. Acta Oncol. 2003 |
| 233 | Beta-catenin | Colon, Rectum | Diagnosis | Wong SC et al. Clin Cancer Res. 2004 |
| 234 | Dihydropyrimidine dehydrogenase (DPD) | Colon, Rectum | Prognosis | Oi K et al. Anticancer Res. 2004 |
| 235 | P65 | Colon, Rectum | Prognosis | Balcerczak M et al. Eur J Surg Oncol. 2004 |
| 236 | Platelet-derived endothelial cell growth factor (PD-ECGF) | Colon, Rectum | Prognosis | Tsuji T et al. Eur J Surg Oncol. 2004 |
| 237 | C-peptide | Colon, Rectum | Diagnosis | Ma J et al. J Natl Cancer Inst. 2004 |
| 238 | Endothelin-1 (ET-1) | Colon, Rectum | Prognosis | Arun C et al. Int J Biol Markers. 2004 |
| 239 | PRL-3 | Colon, Rectum | Prognosis | Peng L et al. J Cancer Res Clin Oncol. 2004 |
| 240 | Dipeptidase 1 (DPEP1) | Colon, Rectum | Diagnosis | McIver CM et al. Cancer Lett. 2004 |
| 241 | The deleted in colorectal cancer (DCC) | Colon, Rectum | Prognosis | Gal R et al. Dis Colon Rectum. 2004 |
| 242 | Tumor M(2)-PK | Colon, Rectum | Diagnosis | Zhang B et al. World J Gastroenterol. 2004 |
| 243 | Soluble (s) P-selectin | Colon, Rectum | Prognosis | Ferroni P et al. Int J Cancer. 2004 |
| 244 | Tenascin-C (TN-C) | Colon, Rectum | Prognosis | Sis B et al. Pathol Res Pract. 2004 |
| 245 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Diagnosis | Celen O et al. Neoplasma. 2004 |
| 246 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon, Rectum | Prognosis | Yukawa N et al. Anticancer Res. 2004 |
| 247 | Cyclooxygenase 2 (COX-2) | Colon, Rectum | Diagnosis | Kanaoka S et al. Gastroenterology. 2004 |
| 248 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Broll R et al. Int J Colorectal Dis. 2005 |
| 249 | Dihydropyrimidine dehydrogenase (DPD) | Colon, Rectum | Treatment | Tsuji T et al. Cancer Chemother Pharmacol. 2004 |
| 250 | Heparanase | Colon, Rectum | Prognosis | Sato T et al. J Surg Oncol. 2004 |
| 251 | Survivin | Colon, Rectum | Diagnosis | Chen WC et al. World J Gastroenterol. 2004 |
| 252 | A3 adenosine receptors | Colon | Diagnosis | Gessi S et al. Clin Cancer Res. 2004 |
| 253 | Cyclo-oxgenase 2 (COX-2) | Colon, Rectum | Prognosis | Zhan J et al. Chin Med J (Engl). 2004 |
| 254 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Marcuello E et al. Int J Cancer. 2004 |
| 255 | Vascular endothelial growth factor(VEGF) | Colon, Rectum | Prognosis | Tamura M et al. J Thorac Cardiovasc Surg. 2004 |
| 257 | Endothelial cell nitric oxide synthase (ecNOS) | Colon, Rectum | Prognosis | Mortensen K et al. Cancer Lett. 2004 |
| 258 | Activated leucocyte cell adhesion molecule (ALCAM) | Colon, Rectum | Prognosis | Weichert W et al. J Clin Pathol. 2004 |
| 260 | P27 (Kip1) | Rectum | Treatment | Moore HG et al. Ann Surg Oncol. 2004 |
| 262 | Fractalkine | Colon, Rectum | Prognosis | Ohta M et al. Int J Oncol. 2005 |
| 263 | Laminin | Colon, Rectum | Prognosis | Saito N et al. Int J Colorectal Dis. 2005 |
| 264 | Matrix metalloproteinase-2 (MMP-2) | Colon, Rectum | Diagnosis | Langenski?ld M et al. Int J Colorectal Dis. 2005 |
| 265 | Methylenetetrahydrofolate reductase (MTHFR) | Colon, Rectum | Treatment | Etienne MC et al. Pharmacogenetics. 2004 |
| 266 | Prolactin (PRL) | Colon, Rectum | Diagnosis | Soroush AR et al. BMC Cancer. 2004 |
| 267 | Matrix metalloproteinase (MMPs), Tissue inhibitors of matrix metalloproteinases (TIMPs) | Colon, Rectum | Prognosis | Curran S et al. Clin Cancer Res. 2004 |
| 268 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Prognosis | Soumaoro LT et al. Clin Cancer Res. 2004 |
| 269 | Heparanase | Colon, Rectum | Prognosis | Nobuhisa T et al. J Cancer Res Clin Oncol. 2005 |
| 270 | Connective tissue growth factor(CTGF) | Colon, Rectum | Prognosis | Lin BR et al. Gastroenterology. 2005 |
| 271 | Cathepsin H | Colon, Rectum | Prognosis | Schweiger A et al. Int J Biol Markers. 2004 |
| 272 | Bcl-2 | Colon, Rectum | Prognosis | Giannoulis K et al. Tech Coloproctol. 2004 |
| 273 | Alphavbeta6 integrin | Colon, Rectum | Prognosis | Bates RC et al. J Clin Invest. 2005 |
| 275 | Cysteine peptidase (CP) | Colon, Rectum | Prognosis | Szwed R et al. World J Gastroenterol. 2005 |
| 276 | Thymidine phosphorylase (TP) | Colon, Rectum | Prognosis | Yasuno M et al. Oncol Rep. 2005 |
| 277 | Particularly interesting new cysteine-histidine-rich protein (PINCH) | Colon, Rectum | Prognosis | Gao J et al. Neoplasia. 2004 |
| 278 | Serine threonine receptor-associated protein (STRAP) | Colon, Rectum | Treatment | Buess M et al. Neoplasia. 2004 |
| 279 | Mannan-binding lectin-associated serine protease 2 (MASP-2) | Colon, Rectum | Prognosis | Ytting H et al. Clin Cancer Res. 2005 |
| 280 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Diagnosis | Xiong B et al. World J Gastroenterol. 2005 |
| 282 | Thymidine phosphorylase (TP) | Colon, Rectum | Treatment | Hasegawa S et al. Oncol Rep. 2005 |
| 283 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Inoue T et al. J Gastroenterol. 2005 |
| 284 | Interleukin 6 (IL-6), C-reactive protein (CRP) | Colon, Rectum | Prognosis | Nikiteas NI et al. World J Gastroenterol. 2005 |
| 286 | Von Willebrand factor (vWF) | Colon, Rectum | Prognosis | Wang WS et al. World J Gastroenterol. 2005 |
| 287 | SMAD4 | Colon, Rectum | Prognosis | Alazzouzi H et al. Clin Cancer Res. 2005 |
| 288 | Epidermal growth factor receptor (EGFR) | Rectum | Prognosis, Treatment | Giralt J et al. Radiother Oncol. 2005 |
| 289 | Ornithine decarboxylase (ODC) | Colon, Rectum | Diagnosis, Treatment | Hu HY et al. World J Gastroenterol. 2005 |
| 290 | Alkaline sphingomyelinase | Colon, Rectum | Diagnosis | Di Marzio L et al. Cancer Epidemiol Biomarkers Prev. 2005 |
| 291 | Placenta growth factor (PlGF) | Colon, Rectum | Prognosis | Wei SC et al. Gut. 2005 |
| 292 | Zeste homolog 2(EZH-2) | Colon, Rectum | Prognosis | Mimori K et al. Eur J Surg Oncol. 2005 |
| 293 | Bax | Colon, Rectum | Treatment | Chang HJ et al. Hum Pathol. 2005 |
| 294 | CYP51 | Colon, Rectum | Prognosis | Kumarakulasingham M et al. Clin Cancer Res. 2005 |
| 295 | Matrix metalloproteinase-2, Metalloproteinase-1 | Colon, Rectum | Prognosis | Waas ET et al. Dis Colon Rectum. 2005 |
| 296 | Ku, p53, p21, p16 | Colon, Rectum | Treatment | Komuro Y et al. Hepatogastroenterology. 2005 |
| 299 | Telomerase reverse transcriptase | Colon, Rectum | Treatment | Komuro Y et al. Hepatogastroenterology. 2005 |
| 300 | Ku70 | Colon, Rectum | Prognosis | Komuro Y et al. Hepatogastroenterology. 2005 |
| 301 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Ohrling K et al. J Clin Oncol. 2005 |
| 302 | Epidermal growth factor receptor (EGFR) | Colon, Rectum | Treatment | Cunningham MP et al. Int J Oncol. 2005 |
| 303 | Soluble urokinase plasminogen activator receptor (suPAR) | Rectum | Prognosis | Riisbro R et al. Int J Biol Markers. 2005 |
| 304 | Insulin-like growth factor-II(IGF-II) | Colon, Rectum | Prognosis | Zhao R et al. Cancer Epidemiol Biomarkers Prev. 2005 |
| 305 | Thymidine kinase (TK) | Colon, Rectum | Treatment | Topolcan O et al. Anticancer Res. 2005 |
| 307 | Cytokeratin 20 (CK20) | Colon, Rectum | Diagnosis | Guo J et al. J Gastroenterol Hepatol. 2005 |
| 308 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Bendardaf R et al. Oncol Rep. 2005 |
| 309 | Galectin-3 | Colon, Rectum | Prognosis | Endo K et al. Anticancer Res. 2005 |
| 310 | Plasminogen activator inhibitor-1 (PAI-1) | Colon, Rectum | Prognosis | Sakakibara T et al. Br J Cancer. 2005 |
| 311 | Thymidine phosphorylase (TP), Dihydropyrimidine dehydrogenase (DPD), Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Lassmann S et al. Int J Colorectal Dis. 2006 |
| 312 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Hitre E et al. Pharmacogenet Genomics. 2005 |
| 313 | Ki-67 | Colon, Rectum | Prognosis | Oshima CT et al. Neoplasma. 2005 |
| 314 | CD59 | Colon, Rectum | Prognosis | Watson NF et al. Cancer Immunol Immunother. 2006 |
| 315 | Nicotinamide N-methyltransferase (NNMT) | Colon, Rectum | Diagnosis | Roessler M et al. Clin Cancer Res. 2005 |
| 316 | CD24 | Colon, Rectum | Prognosis | Weichert W et al. Clin Cancer Res. 2005 |
| 318 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Treatment | Smith FM et al. Int J Radiat Oncol Biol Phys. 2006 |
| 319 | Vascular endothelial growth factor (VEGF) | Rectum | Treatment | Zlobec I et al. Cancer. 2005 |
| 320 | Excision repair cross-complementation group 1 (ERCC1) | Colon, Rectum | Prognosis | Park DJ et al. Clin Adv Hematol Oncol. 2003 |
| 322 | Migration inhibitory factor(MIF) | Colon | Treatment | Yao K et al. Clin Cancer Res. 2005 |
| 323 | Tumour matrilysin | Colon, Rectum | Diagnosis | Kurokawa S et al. Gut. 2005 |
| 325 | Janus kinase 3 (JAK3) | Colon, Rectum | Prognosis | Mori D et al. Pathol Res Pract. 2005 |
| 329 | Carcinoembryonic antigen -IgM (CEA-IgM) | Colon, Rectum | Diagnosis | Castaldi F et al. Int J Biol Markers. 2005 |
| 330 | GlutathioneS-transferase P1 (GSTP1) | Colon, Rectum | Prognosis | Sun XF et al. World J Gastroenterol. 2005 |
| 331 | Cathepsin D (CD) | Colon, Rectum | Diagnosis | Sebzda T et al. J Exp Ther Oncol. 2005 |
| 332 | Bcl-2 | Colon, Rectum | Prognosis | Zavrides H et al. Pol J Pathol. 2005 |
| 333 | Bcl-2 | Colon, Rectum | Prognosis | Chatla C et al. Cancer Biomark. 2005 |
| 334 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Okumura K et al. Cancer Chemother Pharmacol. 2008 |
| 335 | Bcl-2 | Colon, Rectum | Prognosis | Tzouvala M et al. Dig Dis Sci. 2008 |
| 336 | SFRP2 | Colon, Rectum | Diagnosis | Oberwalder M et al. Int J Colorectal Dis. 2008 |
| 337 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Zafirellis K et al. J Surg Res. 2008 |
| 338 | KRAS | Colon, Rectum | Prognosis, Treatment | De Roock W et al. Ann Oncol. 2008 |
| 339 | Colon cancer-specific antigen (CCSA)-2 | Colon | Diagnosis | Walgenbach-Brunagel G et al. J Cell Biochem. 2008 |
| 340 | Thymidylate synthase (TS), MGMT | Colon, Rectum | Treatment | Nakajima TE et al. Eur J Cancer. 2008 |
| 341 | Thymidylate synthase (TS) | Colon, Rectum | Treatment | Negri FV et al. Br J Cancer. 2008 |
| 342 | Methyl-CpG binding domain protein 4 (MBD4) | Colon, Rectum | Prognosis | Xi Y et al. Oncol Rep. 2008 |
| 343 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Kim JG et al. Clin Cancer Res. 2008 |
| 344 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Shiu YC et al. Dis Colon Rectum. 2008 |
| 345 | Immunosuppressive acidic protein (IAP) | Colon, Rectum | Prognosis | Toiyama Y et al. J Surg Oncol. 2008 |
| 346 | Epidermal growth factor receptor (EGFR), Vascular endothelial growth factor (VEGF) | Colon, Rectum | Treatment | Zlobec I et al. Br J Cancer. 2008 |
| 347 | CDA, MGC20553,BANK1, BCNP1, MS4A1 | Colon, Rectum | Diagnosis | Han M et al. Clin Cancer Res. 2008 |
| 348 | BMP7 | Colon, Rectum | Prognosis | Motoyama K et al. Ann Surg Oncol. 2008 |
| 349 | Ribosomal protein L19 (RPL19) | Colon, Rectum | Prognosis | Huang CJ et al. J Cell Mol Med. 2008 |
| 350 | Human leukocyte antigen-DR (HLA-DR) | Colon, Rectum | Prognosis | de Bruin EC et al. Clin Cancer Res. 2008 |
| 351 | Orptate phosphoribosyl transferase (OPRT) | Colon, Rectum | Prognosis | Yamada H et al. Oncol Rep. 2008 |
| 352 | CD44 variant 6 (CD44v6) | Colon, Rectum | Treatment | Peng J et al. Cancer J. 2008 |
| 353 | KRAS | Colon, Rectum | Treatment | Amado RG et al. J Clin Oncol. 2008 |
| 354 | Epidermal growth factor receptor serum (sEGFR) | Colon, Rectum | Prognosis, Treatment | Zampino MG et al. Cancer Chemother Pharmacol. 2008 |
| 355 | Beta-catenin | Colon, Rectum | Prognosis | Chen S et al. Scand J Gastroenterol. 2008 |
| 356 | Soluble intercellular adhesion molecule-1 (sICAM-1) | Colon, Rectum | Prognosis | Toiyama Y et al. Ann Surg Oncol. 2008 |
| 357 | Matrix metalloproteinase-9 (MMP-9) | Colon, Rectum | Prognosis | Unsal D et al. Am J Clin Oncol. 2008 |
| 359 | Survivin | Colon, Rectum | Treatment | Rödel F et al. Int J Radiat Oncol Biol Phys. 2008 |
| 360 | Amphiregulin (AR) | Colon, Rectum | Prognosis | Yamada M et al. Clin Cancer Res. 2008 |
| 362 | Matrix metalloproteinase-2 (MMP-2) | Colon, Rectum | Prognosis | Oshima T et al. Oncol Rep |
| 363 | macrophage migration inhibitory factor (MIF) | Colon, Rectum | Diagnosis | Lee H et al. Am J Clin Pathol. 2008 |
| 364 | Selenium-binding protein 1 (SBP1) | Colon, Rectum | Prognosis | Li T et al. Mol Nutr Food Res. 2008 |
| 366 | PTEN | Colon, Rectum | Prognosis | Colakoglu T et al. Am J Surg. 2008 |
| 367 | Regenerating islet-derived 1 alpha (REG1A) | Colon, Rectum | Prognosis | Astrosini C et al. Int J Cancer. 2008 |
| 369 | Platelet-derived growth factor BB (PDGF-BB) | Colon, Rectum | Prognosis | Nakamura Y et al. Ann Surg Oncol. 2008 |
| 370 | hMLH1 | Colon, Rectum | Treatment | Ide T et al. Oncol Rep. 2008 |
| 371 | β2microglobulin (B2M) | Colon, Rectum | Prognosis | Shrout J et al. Br J Cancer. 2008 |
| 372 | Mitotic centromere-associated kinesin (MCAK) | Colon, Rectum | Prognosis | Ishikawa K et al. Br J Cancer. 2008 |
| 374 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Li M et al. Colorectal Dis. 2009 |
| 376 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Díaz R et al. Int J Cancer. 2008 |
| 377 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Yuan SQ et al. Ai Zheng. 2008 |
| 379 | CK20 | Colon, Rectum | Prognosis | Lugli A et al. Mod Pathol. 2008 |
| 382 | Beta-catenin | Colon, Rectum | Diagnosis | Elzagheid A et al. World J Gastroenterol. 2008 |
| 383 | DYX1C1 | Colon, Rectum | Diagnosis | Kim YJ et al. J Cancer Res Clin Oncol. 2009 |
| 384 | Beta-catenin | Colon, Rectum | Prognosis | Suzuki H et al. Anticancer Res. 2008 |
| 385 | Formin-like 2 (FMNL2) | Colon, Rectum | Diagnosis | Zhu XL et al. Int J Colorectal Dis. 2008 |
| 387 | Microtubule associated protein 7 (Map7)/B2M | Colon | Prognosis | Blum C et al. Int J Oncol. 2008 |
| 389 | CD133 | Colon, Rectum | Prognosis | Horst D et al. Br J Cancer. 2008 |
| 392 | Carcinoembryonic antigen (CEA) | Colon, Rectum | Prognosis | Takagawa R et al. Ann Surg Oncol. 2008 |
| 393 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Koike Y et al. J Surg Oncol. 2008 |
| 394 | RHAMM, CD8(+) TILs | Colon, Rectum | Prognosis | Zlobec I et al. Br J Cancer. 2008 |
| 395 | HuR | Colon, Rectum | Prognosis | Yoo PS et al. Ann Surg Oncol. 2009 |
| 396 | hTERT transcripts (hTERT-AT) | Colon, Rectum | Diagnosis | Terrin L et al. Clin Cancer Res. 2008 |
| 397 | Cyclooxygenase-2 (COX-2) | Colon, Rectum | Treatment | Min BS et al. Arch Surg. 2008 |
| 398 | Insulin-like growth factor-1 receptor (IGF-1R) | Colon, Rectum | Treatment | Takahari D et al. Oncology. 2009 |
| 399 | Leptin | Colon, Rectum | Prognosis | Paik SS et al. Ann Surg Oncol. 2009 |
| 401 | CEA | Colon, Rectum | Prognosis | Park JW et al. Int J Radiat Oncol Biol Phys. 2009 |
| 402 | CXCR4 | Colon, Rectum | Prognosis | Speetjens FM et al. Cancer Microenviron. 2009 |
| 403 | Cyclin D2 | Colon, Rectum | Prognosis | Sarkar R et al. Colorectal Dis. 2010 |
| 404 | HSP70 | Colon, Rectum | Prognosis | Kocsis J et al. Cell Stress Chaperones. 2010 |
| 405 | Urokinase-type plasminogen activator (uPA) | Rectum | Prognosis | Minoo P et al. Hum Pathol. 2010 |
| 406 | Osteopontin (OPN) | NA | Prognosis | Likui W et al. J Gastrointest Surg. 2010 |
| 408 | CXCL10 | Colon, Rectum | Prognosis | Jiang Z et al. Mol Biol Rep. 2010 |
| 409 | IQGAP1 | NA | Prognosis | Hayashi H et al. Int J Cancer. 2010 |
| 410 | High-mobility group box 1 (HMGB1) | Colon, Rectum | Prognosis | Yao X et al. J Cancer Res Clin Oncol. 2010 |
| 411 | Survivin | Colon, Rectum | Prognosis | Xiaoyuan C et al. Ir J Med Sci. 2010 |
| 412 | Transgelin-2 (TAGLN2) | Colon, Rectum | Prognosis | Zhang Y et al. Cancer Sci. 2010 |
| 413 | P73 | NA | Prognosis | Toumi AA et al. Appl Immunohistochem Mol Morphol. 2010 |
| 414 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis, Treatment | Ahn MJ et al. Cancer Res Treat. 2005 |
| 415 | S100A14, S100A4 | Colon, Rectum | Prognosis | Wang HY et al. Oncol Rep. 2010 |
| 416 | Prominin-1 (CD133) | Colon, Rectum | Diagnosis, Treatment | Artells R et al. Eur J Cancer. 2010 |
| 417 | Transglutaminase 2 (TGM2) | NA | Prognosis, Treatment | Miyoshi N et al. Ann Surg Oncol. 2010 |
| 419 | ATP11A | NA | Prognosis | Miyoshi N et al. Oncol Rep. 2010 |
| 420 | Notch1 | Colon, Rectum | Prognosis | Chu D et al. Ann Surg Oncol. 2010 |
| 422 | TLR4, myeloid differentiation factor 88 (MyD88) | NA | Prognosis | Wang EL et al.Br J Cancer. 2010 |
| 423 | Cellular apoptosis susceptibility (CSE1L/CAS) protein | Colon, Rectum | Prognosis | Stella Tsai CS et al. Am J Pathol. 2010 |
| 424 | IGF-binding protein (IGFBP)-2 | NA | Diagnosis, Prognosis | Liou JM et al. J Clin Endocrinol Metab. 2010 |
| 425 | MUC12 | Colon, Rectum | Prognosis | Matsuyama T et al. Int J Cancer. 2010 |
| 426 | Thymidylate synthase (TS) | NA | Prognosis | Páez D et al. J Cancer Res Clin Oncol. 2010 |
| 427 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Karlberg M et al. Anticancer Res. 2010 |
| 428 | CD95 | NA | Prognosis | Han SL et al. Int J Colorectal Dis. 2010 |
| 429 | hMLH1 | Colon, Rectum | Treatment | Park IJ et al. Cancer Res Treat. 2004 |
| 432 | Vascular endothelial growth factor (VEGF) | NA | Prognosis | Kwon KA et al. BMC Cancer. 2010 |
| 433 | Soluble urokinase plasminogen activator receptor (suPAR) | Colon, Rectum | Prognosis | Lomholt AF et al. Acta Oncol. 2010 |
| 435 | Stomatin-like protein 2 | Colon, Rectum | Treatment | Yeoh LC et al. World J Gastroenterol. 2010 |
| 436 | Prefoldin 4 (PFDN4) | NA | Prognosis | Miyoshi N et al. Ann Surg Oncol. 2010 |
| 437 | Prion protein, PrP(C) | Colon, Rectum | Prognosis, Treatment | Antonacopoulou AG et al. Mol Carcinog. 2010 |
| 438 | P16 | Colon, Rectum | Prognosis | Karamitopoulou E et al. Cancer. 2010 |
| 439 | Polo-like kinase 1 (PLK1) | NA | Treatment | Rödel F et al. Am J Pathol. 2010 |
| 440 | Prohibitin (PHB) | Colon, Rectum | Diagnosis | Chen D et al. Int J Oncol. 2010 |
| 441 | Matrix metalloproteinases (MMPs) | NA | Prognosis | Tahara K et al. Ann Surg Oncol. 2010 |
| 442 | Tissue inhibitor of metalloproteinases-1 (TIMP-1) | Colon, Rectum | Prognosis | Birgisson H et al.?Eur J Cancer. 2010 |
| 444 | Cyclin E | Colon, Rectum | Prognosis | Perea J et al. World J Gastroenterol. 2010 |
| 445 | Metastasis-associated in colon cancer 1 (MACC1) | NA | Prognosis | Shirahata A et al. Anticancer Res. 2010 |
| 446 | S100A4 | NA | Prognosis | Kwak JM et al. World J Gastroenterol. 2010 |
| 447 | S100A4 | NA | Prognosis | Boye K et al. Eur J Cancer. 2010 |
| 448 | ESM-1 | NA | Diagnosis | Ji NY et al. Cancer Sci. 2010 |
| 450 | Jumonji domain containing 1A (JMJD1A) | NA | Prognosis, Treatment | Uemura M et al. Clin Cancer Res. 2010 |
| 451 | C4.4A | NA | Prognosis | Konishi K et al. Cancer Sci. 2010 |
| 452 | Tumour-associated trypsin inhibitor (TATI) | Colon, Rectum | Prognosis | Gaber A et al. BMC Cancer. 2010 |
| 454 | Ankyrin repeat, SOCS box-containing 9 (ASB9) | NA | Prognosis | Tokuoka M et al. Int J Oncol. 2010 |
| 455 | Matrix metalloproteinase 13 (MMP13) | NA | Prognosis | Huang MY et al. Oncol Rep. 2010 |
| 457 | Phospholipid scramblase 1 (PLSCR1) | NA | Diagnosis, Prognosis | Kuo YB et al. Mol Med. 2011 |
| 458 | Heat shock protein 27 (HSP27) | NA | Prognosis | Tweedle EM et al. Gut. 2010 |
| 459 | Toll like receptor 4 (TLR4) | Colon, Rectum | Prognosis | Cammarota R et al. J Transl Med. 2010 |
| 461 | Survivin | NA | Prognosis | Sprenger T et al. Clin Cancer Res. 2011 |
| 462 | PTPRG | NA | Diagnosis | van Roon EH et al. Eur J Hum Genet. 2011 |
| 463 | Peroxisome proliferator-activated receptor γ (PPARG) | NA | Prognosis | Pancione M et al. PLoS One. 2010 |
| 464 | NHERF1 | NA | Diagnosis | Hayashi Y et al. Neoplasia. 2010 |
| 465 | Mus81 | Colon, Rectum | Prognosis | Wu F et al. Cancer Sci. 2011 |
| 466 | Matrix metalloproteinase-7 (MMP-7) | Colon, Rectum | Prognosis | Koskensalo S et al. Tumour Biol. 2011 |
| 467 | STOML2 | NA | Diagnosis | Han CL et al. Mol Cell Proteomics. 2011 |
| 468 | S100A4 | Colon, Rectum | Prognosis | Huang LY et al. World J Gastroenterol. 2011 |
| 469 | Brachyury | NA | Prognosis | Kilic N et al. Eur J Cancer. 2011 |
| 470 | NDRG2 (N-Myc downstream-regulated gene 2) | Colon, Rectum | Prognosis | Chu D et al. Mol Cancer Ther. 2011 |
| 472 | Second mitochondria-derived activator of caspase (Smac)? | Rectum | Prognosis | Yan H et al. Med Oncol. 2012 |
| 474 | Bcl-Xl | Colon, Rectum | Prognosis | Jin-Song Y et al. Acta Histochem. 2011 |
| 475 | Forkhead box M1 (FOXM1) | Colon, Rectum | Treatment | Uddin S et al. Am J Pathol. 2011 |
| 476 | Thymidylate synthase (TS) | Rectum | Prognosis | Conradi LC et al. Ann Surg Oncol. 2011 |
| 477 | Sperm-associated antigen 9 gene (SPAG9) | NA | Diagnosis | Kanojia D et al. Am J Pathol. 2011 |
| 478 | CK2α | NA | Prognosis | Lin KY et al. PLoS One. 2011 |
| 482 | Interleukin 17 (IL-17) | Colon, Rectum | Prognosis | Liu J et al. Biochem Biophys Res Commun. 2011 |
| 485 | Matrix metalloproteinase-9 (MMP-9) | Colon, Rectum | Prognosis | Chu D et al. Ann Surg Oncol. 2012 |
| 486 | Growth differentiation factor 15 (GDF15) | NA | Prognosis | Wallin U et al. Br J Cancer. 2011 |
| 487 | HOXB7 | NA | Prognosis | Liao WT et al. Clin Cancer Res. 2011 |
| 488 | Kallikrein-related peptidase 10 (KLK10) | NA | Prognosis | Talieri M et al. Tumour Biol. 2011 |
| 489 | SPG20 (spastic paraplegia-20) | NA | Diagnosis | Lind GE et al. Oncogene. 2011 |
| 490 | Urokinase-type plasminogen activator (uPA), Proliferating cell nuclear antigen labeling index (PCNA-LI) | Colon, Rectum | Prognosis | Tatsuta S et al. Int J Oncol. 1997 |
| 491 | Rabphilin-3A-like (RPH3AL) | Colon, Rectum | Diagnosis | Chen JS et al. Clin Chim Acta. 2011 |
| 492 | CEA | Colon, Rectum | Prognosis | Lin JK et al. Int J Colorectal Dis. 2011 |
| 493 | Connective tissue growth factor (CTGF) | Colon, Rectum | Treatment | Lin BR et al. Clin Cancer Res. 2011 |
| 494 | ADAMTS12 | Colon, Rectum | Prognosis | Wang D et al. Dig Dis Sci. 2011 |
| 495 | Metastasis suppressor 1 (MTSS1) | Colon, Rectum | Prognosis | Wang D et al. J Gastrointest Surg. 2011 |
| 497 | Matrix metalloproteinase-21 (MMP-21) | Colon, Rectum | Prognosis | Huang Y et al. J Gastrointest Surg. 2011 |
| 498 | p53 | NA | Prognosis | Dastjerdi MN et al. Acta Med Iran. 2011 |
| 500 | α(1,6)fucosyltransferase | Colon, Rectum | Prognosis | Muinelo-Romay L et al. Hum Pathol. 2011 |
| 501 | MMP-21 | Colon, Rectum | Prognosis | Wu T et al. J Surg Oncol. 2011 |
| 502 | Rho GDP dissociation inhibitor 2 (RhoGDI2) | Colon, Rectum | Prognosis | Fujita A et al. Int J Clin Oncol. 2012 |
| 503 | Neurone glial-related cell adhesion molecule (Nr-CAM) | Colon, Rectum | Prognosis | Chan JY et al. Cancer Sci. 2011 |
| 504 | Claudin1 (CLDN1) | NA | Prognosis | Nakagawa S et al. Int J Oncol. 2011 |
| 505 | Epidermal growth factor-like domain 7 (EGFL7) | NA | Prognosis | Wu F et al. Anticancer Res. 2011 |
| 506 | Testes-specific protease 50 (TSP50) | Colon, Rectum | Prognosis | Zheng L et al. PLoS One. 2011 |
| 507 | Notch1 | Colon, Rectum | Prognosis | Chu D et al. Clin Cancer Res. 2011 |
| 509 | Bag-1 | NA | Diagnosis, Prognosis | Sun NF et al. J Cancer Res Clin Oncol. 2011 |
| 510 | Eukaryotic initiation factor 5A2 (EIF5A2) | NA | Prognosis, Treatment | Zhu W et al. Gut. 2012 |
| 511 | Podocalyxin-like 1 (PODXL) | Colon, Rectum | Prognosis | Larsson A et al. Br J Cancer. 2011 |
| 512 | CXCL16 | NA | Prognosis | Matsushita K et al. Ann Surg Oncol. 2012 |
| 513 | Transketolase like gene 1 (TKTL1) | NA | Prognosis | Schwaab J et al. BMC Cancer. 2011 |
| 514 | Claudin-1 (CL-1) | Rectum | Prognosis | Yoshida T et al. Anticancer Res. 2011 |
| 515 | Secreted Protein Acidic, Rich in Cysteine (SPARC) | Colon, Rectum | Diagnosis, Prognosis | Zhang H et al. Tumour Biol. 2011 |
| 517 | Cyclin E | NA | Prognosis | Zhou YJ et al. Eur J Surg Oncol. 2011 |
| 518 | RNA-binding motifs 3 (RBM3) | Colon, Rectum | Prognosis | Hjelm B et al. Proteomics Clin Appl. 2011 |
| 519 | Rpt4 | Colon, Rectum | Prognosis | McCawley N et al.?Int J Cancer. 2012 |
| 520 | Matrix metalloproteinase-2 (MMP-2) | Colon, Rectum | Prognosis | Dong W et al. Acta Biochim Biophys Sin (Shanghai). 2011 |
| 522 | Leukocyte Antigen (HLA)-E | NA | Prognosis | Benevolo M et al. J Transl Med. 2011 |
| 523 | CXCL10 | NA | Prognosis | Toiyama Y et al. Int J Oncol. 2012 |
| 524 | E-box-binding homeobox 2 (ZEB2) | NA | Prognosis, Treatment | Kahlert C et al. Clin Cancer Res. 2011 |
| 527 | Visinin-like protein-1 (VSNL-1) | NA | Prognosis | Akagi T et al. Int J Cancer. 2012 |
| 528 | Pleiotrophin (PTN) | Colon, Rectum | Prognosis, Treatment | Kong Y et al. Int J Colorectal Dis. 2012 |
| 530 | Glucose transporter 1 (GLUT1) | NA | Diagnosis | Saigusa S et al. Surg Today. 2012 |
| 531 | Indoleamine 2,3-dioxygenase 1 (IDO1) | NA | Prognosis | Ferdinande L et al. Br J Cancer. 2012 |
| 533 | Stathmin-1 (STMN1) | Colon, Rectum | Prognosis | Tan HT et al. J Proteome Res. 2012 |
| 534 | CXCL5 | NA | Prognosis | Kawamura M et al.Eur J Cancer. 2012 |
| 535 | Ubiquitin-like with plant homeodomain, ring finger domains 1 (UHRF1) | Colon, Rectum | Treatment | Wang F et al. Ann Surg Oncol. 2012 |
| 536 | Mitochondrial transcription factor A (mtTFA) | Colon, Rectum | Prognosis | Nakayama Y et al. Oncol Rep. 2012 |
| 538 | Kallikrein-related peptidase 6 (KLK6) | NA | Prognosis | Petraki C et al. Pathol Res Pract. 2012 |
| 539 | CD73 | Colon, Rectum | Prognosis | Wu XR et al. J Surg Oncol. 2012 |
| 540 | E-cadherin | NA | Prognosis | Chen X et al. Mol Biol Rep. 2012 |
| 542 | FOXM1 | Colon, Rectum | Prognosis | Chu XY et al. Acta Histochem. 2012 |
| 543 | Special AT-rich sequence-binding protein 2 (SATB2) | NA | Prognosis | Eberhard J et al. Br J Cancer. 2012 |
| 545 | ORM2 | NA | Diagnosis | Zhang X et al. PLoS One. 2012 |
| 546 | Reversion-inducing cysteine-rich protein with Kazal motif (RECK)? | NA | Prognosis | Stenzinger A et al. Hum Pathol. 2012 |
| 547 | CXCR3 | Colon, Rectum | Prognosis, Treatment | Wu Z et al. Biomed Pharmacother. 2012 |
| 548 | Aldehyde dehydrogenase 1 (ALDH1) | Colon, Rectum | Treatment | Hessman CJ et al. Am J Surg. 2012 |
| 549 | Kallikrein-related peptidase 10 (KLK10) | NA | Prognosis | Petraki C et al. Tumour Biol. 2012 |
| 550 | PITX1 | Colon, Rectum | Prognosis | Knsel T et al. Int J Colorectal Dis. 2012 |
| 552 | B7-H3 | Colon, Rectum | Prognosis | Ingebrigtsen VA et al. Int J Cancer. 2012 |
| 555 | EFEMP2 | Colon, Rectum | Diagnosis | Yao L et al. J Proteome Res. 2012 |
| 556 | Metallothionein, p53 | Rectum | Prognosis | Arriaga JM et al. Hum Pathol. 2012 |
| 557 | FANCJ | NA | Prognosis | Nakanishi R et al. Ann Surg Oncol. 2012 |
| 558 | RalBP1 | NA | Prognosis, Treatment | Mollberg NM et al. Cancer Biol Ther. 2012 |
| 560 | S100P | Rectum | Prognosis | Wang Q et al. Oncol Rep. 2012 |
| 561 | Cyclooxygenase-2 (COX-2) | Colon | Prognosis | Al-Maghrabi J et al. World J Gastroenterol. 2012 |
| 563 | Rsf-1 (HBXAP) | Rectum | Prognosis | Lin Cy et al. J Clin Pathol. 2012 |
| 564 | lysosome-associated protein transmembrane-4 beta (LAPTM4B) | Colon, Rectum | Prognosis | Kang Y et al. Am J Surg. 2012 |
| 566 | Matrix metalloproteinase-7 (MMP-7) | NA | Prognosis | Yang B et al. Asian Pac J Cancer Prev. 2012 |
| 568 | Amphiregulin (AR) | Colon, Rectum | Prognosis | Ohchi T et al. Anticancer Res. 2012 |
| 570 | Cyclooxygenase-2 (COX-2) | NA | Diagnosis, Treatment | Li ZG et al. Oncol Rep. 2012 |
| 571 | Girdin | NA | Prognosis | Liu C et al. Mol Biol Rep. 2012 |
| 572 | Kallikrein-related peptidase 6 (KLK6) | Rectum | Prognosis | Ohlsson L et al. Br J Cancer. 2012 |
| 574 | Carcinoembryonic antigen(CEA) | Rectum | Prognosis | Tarantino I et al. Br J Cancer. 2012 |
| 575 | M2-pyruvate kinase (M2-PK) | NA | Diagnosis | Meng W et al. 22737276 |
| 576 | CD133 | Colon, Rectum | Prognosis | Jao SW et al. Ann Surg Oncol. 2012 |
| 578 | JMJD2B | NA | Treatment | Fu L et al. Carcinogenesis. 2012 |
| 580 | MSP5 | Colon, Rectum | Prognosis | Shi H et al. Med Oncol. 2012 |
| 581 | Extracellular matrix metalloproteinase inducer (EMMPRIN). | Colon, Rectum | Prognosis | Boye K et al. Br J Cancer. 2012 |
| 582 | WRAP53 | NA | Prognosis | Zhang H et al. BMC Cancer. 2012 |
| 583 | Insulin-like growth factor 2 messenger RNA binding protein 3 (IGF2BP3). | Colon, Rectum | Prognosis | Lochhead P et al. Eur J Cancer. 2012 |
| 585 | EPAS1 | Rectum | Prognosis | Mohammed N et al. Oncol Lett. 2011 |
| 586 | Phosphatase, tensin homolog (PTEN) | Colon, Rectum | Prognosis | Lin MS et al. Oncol Lett. 2011 |
| 590 | Macrophage inflammatory protein-3 alpha (MIP-3a) | NA | Prognosis | Iwata T et al. J Surg Oncol. 2013 |
| 591 | Melanoma antigen D1 (MAGED1) | Colon, Rectum | Prognosis | Zeng ZL et al. J Transl Med. 2012 |
| 592 | RhoE | Colon, Rectum | Prognosis | Zhou J et al. Ann Surg Oncol. 2013 |
| 593 | Matrix metalloproteinase-13 (MMP-13) | NA | Prognosis | Yang B et al. Scand J Clin Lab Invest. 2012 |
| 594 | Ras-like nuclear protein (Ran) | NA | Prognosis | Fan H et al. Int J Clin Oncol. 2013 |
| 595 | Monocarboxylate transporter 4 (MCT4) | NA | Prognosis | Nakayama Y et al. Exp Ther MED. 2012 |
| 596 | Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) | Colon | Prognosis, Treatment | Kim KS et al. Clin Chim Acta. 2013 |
| 599 | Autophagy-related gene 5 (ATG5) | NA | Diagnosis, Prognosis | Cho DH et al. Anticancer Res. 2012 |
| 600 | Cytokeratin 18 (CK18) | NA | Prognosis | Greystoke A et al. Br J Cancer. 2012 |
| 603 | NUCKS1 | NA | Prognosis, Treatment | Kikuchi A et al. Int J Cancer. 2013 |
| 604 | Cathepsin X (Cat X) | Colon, Rectum | Prognosis | Vizin T et al. Radiol Oncol. 2012 |
| 605 | Integrin-linked kinase (ILK) | Colon, Rectum | Prognosis | Li R et al. J Mol Histol. 2013 |
| 608 | Tumor necrosis factor receptor-associated protein 1 (TRAP1) | Colon, Rectum | Prognosis | Gao JY et al. World J Gastroenterol. 2012 |
| 609 | Aquaporin5 (AQP5) | NA | Prognosis | Wang W et al. World J Surg Oncol. 2012 |
| 611 | Deleted in liver cancer 2 (DLC2) | Colon, Rectum | Prognosis | Gao K et al. Oncol Lett. 2012 |
| 613 | KRAS | Colon, Rectum | Prognosis | Nakanishi R et al.?Int J Clin Oncol. 2013 |
| 614 | BRD7 | Colon, Rectum | Prognosis | Wu WJ et al. Eur J Clin Invest. 2013 |
| 615 | Matrix metalloproteinases (MMPs) | Colon, Rectum | Prognosis | Koskensalo S et al. BMC Clin Pathol. 2012 |
| 616 | EGFR, Her2 | Colon, Rectum | Prognosis | Lu Y et al. Cancer Biomark. 2012 |
| 619 | Ephrin-A1 (EFNA1) | Colon, Rectum | Prognosis | Yamamoto H et al. Int J Oncol. 2013 |
| 620 | Plasminogen activator ihnibitor-1 (PAI-1) | Colon, Rectum | Prognosis | Halamkova J et al. Neoplasma. 2013 |
| 621 | Hepatitis A virus cellular receptor 1 (HAVcR-1) | NA | Diagnosis, Prognosis | Wang Y et al. Anticancer Res. 2013 |
| 623 | Paxillin (PXN) | NA | Prognosis | Chen DL et al. Carcinogenesis. 2013 |
| 625 | Deleted in breast cancer 1 (DBC1) | Colon, Rectum | Prognosis | Zhang Y et al. Int J Clin Oncol. 2014 |
| 627 | SLIT2 | NA | Prognosis | Chen WF et al. Int J Colorectal Dis. 2013 |
| 628 | Telomere-specific reverse transcriptase (hTERT) | Colon, Rectum | Prognosis | Bertorelle R et al. Br J Cancer. 2013 |
| 629 | AC133 | Colon, Rectum | Prognosis | Ying X et al. Med Oncol. 2013 |
| 630 | S-phase kinase-associated protein 2 (SKP2) | NA | Prognosis, Treatment | Tian YF et al. Tumour Biol. 2013 |
| 631 | Tropomyosin receptor kinases B, C (TrkB, C) | NA | Diagnosis, Treatment | Sasahira T et al. Hum Pathol. 2013 |
| 632 | TAZ | NA | Prognosis, Treatment | Yuen HF et al. PLoS One. 2013 |
| 633 | Plastin-3 (PLS3) | NA | Prognosis | Yokobori T et al. Cancer Res. 2013 |
| 634 | Zinc finger E-box binding homeobox 1 (ZEB1) | Colon, Rectum | Prognosis | Zhang GJ et al. Oncol Lett. 2013 |
| 635 | GATA-binding protein 2 (GATA2) | Colon, Rectum | Prognosis | Chen L et al. Med Oncol. 2013 |
| 636 | TRIM28 | Colon, Rectum | Prognosis | Fitzgerald S et al. J Gastroenterol Hepatol. 2013 |
| 637 | CCL18 | Colon, Rectum | Prognosis | Yuan R et al. J Surg Res. 2013 |
| 638 | OV-6 | NA | Prognosis | Lin CH et al. Histopathology. 2013 |
| 640 | Annexin A2 (ANXA2 | Colon, Rectum | Diagnosis, Prognosis | Yang T et al. Colorectal Dis. 2013 |
| 641 | Kallikrein-related peptidase (KLK) | NA | Prognosis | Alexopoulou DK et al. Clin Biochem. 2013 |
| 642 | BRCA1-associated protein 1 (BAP1) | Colon, Rectum | Prognosis | Tang J et al. Med Oncol. 2013 |
| 644 | Yes-associated protein (YAP) | NA | Prognosis | Wang Y et al. Tumour Biol. 2013 |
| 645 | p53 | Colon, Rectum | Prognosis | Huh JW et al. J Am Coll Surg. 2013 |
| 646 | P27 (Kip1) | Colon, Rectum | Prognosis | Pucciarelli et al. Colorectal Dis. 1999 |
| 647 | Gankyrin | NA | Prognosis, Treatment | Bai Z et al. Cancer Res. 2013 |
| 649 | Calcium activated chloride channel A1 (CLCA1) | NA | Prognosis | Yang B et al. PLoS One. 2013 |
| 650 | PLAC1/CP1 | NA | Prognosis | Liu F et al. J Gastroenterol. 2014 |
| 651 | Spleen tyrosine kinase (Syk) | Colon, Rectum | Prognosis | Yang Z et al. Med Oncol. 2013 |
| 653 | Twist2 | Colon, Rectum | Prognosis | Yu H et al. World J Gastroenterol. 2013 |
| 654 | Cryptochrome 1 (Cry1) | Colon, Rectum | Prognosis, Treatment | Yu H et al. PLoS One. 2013 |
| 657 | Carbonic anhydrase II (CA II) | NA | Diagnosis | Zhou R et al. Int J Oncol. 2013 |
| 659 | STAT3 | NA | Prognosis | Gordziel C et al. Br J Cancer. 2013 |
| 660 | Four-and-a-half LIM domains protein 2 (FHL2) | NA | Prognosis | Verset L et al. Br J Cancer. 2013 |
| 661 | Cell division cycle 20 homolog (CDC20) | Colon, Rectum | Prognosis | Wu WJ et al. J Transl Med. 2013 |
| 662 | CCL21 | NA | Prognosis | Zou Y et al. Oncol Rep. 2013 |
| 663 | Serum carcinoembryonic antigen (s-CEA) | Colon, Rectum | Prognosis | Kim CW et al. Ann Surg Oncol. 2013 |
| 666 | MUC20 | Colon, Rectum | Prognosis | Xiao X et al. J Transl Med. 2013 |
| 667 | Soluble a-proliferation-inducing ligand (sAPRIL) | NA | Diagnosis | Ding W et al. Clin Biochem. 2013 |
| 668 | Toll like receptor 4 (TLR4) | Rectum | Prognosis | Eir? N et al. J Immunother. 2013 |
| 669 | G-protein-coupled receptor 48 (GPR48) | Colon, Rectum | Prognosis, Treatment | Wu J et al. Carcinogenesis. 2013 |
| 670 | Paired related homoeobox 1 (PRRX1) | NA | Prognosis | Takahashi Y et al. Br J Cancer. 2013 |
| 671 | Thymidylate synthase (TYMS) | Colon, Rectum | Prognosis | Lu Y et al. Clin Biochem. 2013 |
| 672 | Podocalyxin-like 1 (PODXL) | NA | Prognosis, Treatment | Larsson AH et al. Diagn Pathol. 2013 |
| 674 | S100A10 | Colon, Rectum | Prognosis, Treatment | Shang J et al. Tumour Biol. 2013 |
| 675 | C-reactive protein (CRP) | NA | Prognosis | Toiyama Y et al. Oncol Lett. 2013 |
| 676 | G-protein-coupled receptor 120 (GPR120) | NA | Treatment | Wu Q et al. Oncogene. 2013 |
| 679 | Secreted protein acidic, rich in cysteine (SPARC) | NA | Prognosis | Kim JY et al. Ann Coloproctol. 2013 |
| 680 | N-myc downregulated gene 1 (NDRG1) | Colon, Rectum | Prognosis | Mao Z et al. PLoS One. 2013 |
| 682 | Kininogen-1 | NA | Diagnosis | Wang J et al. PLoS One. 2013 |
| 684 | Claudin-1 | Colon, Rectum | Prognosis | Shibutani M et al. Anticancer Res. 2013 |
| 685 | DEK | Colon, Rectum | Prognosis | Lin L et al. BMC Cancer. 2013 |
| 686 | Visfatin | NA | Diagnosis | Chen M et al. Asia Pac J Clin Oncol. 2016 |
| 687 | Hv1 | Colon, Rectum | Diagnosis, Prognosis, Treatment | Wang Y et al. PLoS One. 2013 |
| 688 | T-box2 (TBX2) | NA | Prognosis, Treatment | Han Y et al. Med Oncol. 2013 |
| 691 | Protein tyrosine phosphatase 1B (PTP1B) | Colon, Rectum | Prognosis | Chen Q et al. J Mol Histol. 2014 |
| 693 | Maspin | Rectum | Prognosis | Snoeren N et al. Br J Cancer. 2013 |
| 695 | Interleukin-10 (IL10) | NA | Prognosis | Ting WC et al. J Korean Med Sci. 2013 |
| 698 | Interleukin 35 (IL-35) | NA | Prognosis | Zeng JC et al. Int J Clin Exp Pathol. 2013 |
| 700 | HS1-associated protein X-1 (HAX-1) | Colon, Rectum | Prognosis, Treatment | Wei XJ et al. Tumour Biol. 2014 |
| 702 | Transmembrane protease/serine 4 (TMPRSS4) | Colon | Prognosis | Huang A et al. Med Oncol. 2013 |
| 703 | Inhibin β A (INHBA) | NA | Prognosis | Okano M et al. Oncol Rep. 2013 |
| 707 | Aurora kinase A (AURKA) | Colon, Rectum | Prognosis | Goos JA et al. Br J Cancer. 2013 |
| 709 | Serpin B5 | Colon, Rectum | Prognosis | Baek JY et al. Int J Cancer. 2014 |
| 710 | Topoisomerase-1 (TOPO1) | NA | Prognosis | Negri FV et al. Anticancer Res. 2013 |
| 713 | DVL1 | NA | Diagnosis, Prognosis | Huang MY et al. Int J Mol Sci. 2013 |
| 714 | Anaplastic lymphoma kinase (ALK) | NA | Prognosis | Bavi P et al. Br J Cancer. 2013 |
| 715 | Fibroblast growth factor receptor 1 (FGFR1) | Colon, Rectum | Treatment | Goke F et al. Digestion. 2013 |
| 716 | The dipeptidyl peptidase IV (DPPIV) | NA | Prognosis | Park HS et al. Yonsei Med J. 2013 |
| 717 | Dachshund homolog 1 (DACH1) | NA | Diagnosis, Prognosis | Yan W et al. Epigenetics. 2013 |
| 721 | TP53 | NA | Prognosis | Singamsetty GK et al. Tumour Biol. 2014 |
| 722 | Lemur tyrosine kinase-3 (LMTK3) | Colon, Rectum | Prognosis | Shi H et al. Med Oncol. 2013 |
| 723 | Bax-interacting factor-1 (Bif-1) | Colon, Rectum | Prognosis | Ko YH et al. Biomed Res Int. 2013 |
| 724 | Epidermal growth factor receptor (EGFR) | Colon, Rectum | Prognosis | Koskensalo S et al. PLoS One. 2013 |
| 725 | Plastin-3 (PLS3) | NA | Prognosis | Sugimachi K et al. Ann Surg Oncol. 2014 |
| 726 | C-reactive protein (CRP) | Rectum | Prognosis | Toiyama Y et al. Anticancer Res. 2013 |
| 727 | Cadherin 12 (CDH12) | Colon, Rectum | Diagnosis, Prognosis, Treatment | Zhao J et al. J Transl Med. 2013 |
| 729 | C-reactive protein (CRP) | NA | Prognosis | Lin M et al. Exp Ther Med. 2013 |
| 730 | KRAS | NA | Prognosis | Spindler KG et al. Br J Cancer. 2013 |
| 731 | Bmal1 | NA | Prognosis, Treatment | Zeng ZL et al. Clin Cancer Res. 2014 |
| 735 | Matrilysin-2 (MMP-26) | NA | Prognosis | Hu Q et al. Tumour Biol. 2014 |
| 736 | Carbonic anhydrase IX (CA9) | Rectum | Prognosis | Schweiger T et al. Eur J Cardiothorac Surg. 2014 |
| 738 | BIRC5 (Survivin) | Colon, Rectum | Diagnosis, Prognosis | Wang H et al. J Surg Oncol. 2014 |
| 739 | AT-rich interactive domain 3A (ARID3A) | Colon, Rectum | Prognosis | Song M et al. Ann Surg Oncol. 2014 |
| 740 | Vasohibin-1 | NA | Prognosis | Yan Y et al. Med Oncol. 2014 |
| 742 | S100P | NA | Prognosis, Treatment | Dong L et al. Mol Cell Biochem. 2014 |
| 743 | CXCR4 | NA | Prognosis | Gao Y et al. Tumour Biol. 2014 |
| 747 | The overexpressed in lung cancer-1 (OLC1) | Colon, Rectum | Prognosis | Liu J et al. Anticancer Res. 2014 |
| 748 | Golgi phosphoprotein 3 (GOLPH3) | Colon, Rectum | Prognosis | Wang Z et al. J Transl Med. 2014 |
| 749 | hMOF | NA | Diagnosis | Cao L et al. Int J Oncol. 2014 |
| 750 | YKL-40 | Colon, Rectum | Prognosis | Tarpgaard LS et al. PLoS One. 2014 |
| 751 | Carcinoembryonic antigen (CEA) | NA | Prognosis | Hotta T et al. Surg Today. 2014 |
| 753 | Carcinoembryonic antigen (CEA) | Rectum | Prognosis | Huang CS et al. Am J Surg. 2014 |
| 755 | Thymine DNA glycosylase (TDG) | NA | Treatment | Xu X et al. J Biol Chem. 2014 |
| 756 | HLA class II antigen | NA | Prognosis | Sconocchia G et al. Neoplasia. 2014 |
| 757 | Secretoglobin, family 2A, member 1 (SCGB2A1) | NA | Prognosis | Munakata K et al. Int J Oncol. 2014 |
| 759 | Cysteine-rich angiogenic inducer 61 (CYR61) | NA | Prognosis | Jeong D et al. BMC Cancer. 2014 |
| 763 | Lipocalin-2 (Lcn-2) | NA | Prognosis | Maier HT et al. World J Surg. 2014 |
| 765 | Lemur tyrosine kinase-3 (LMTK3) | Colon, Rectum | Prognosis | Shi H et al. Int J Clin Exp Pathol. 2014 |
| 768 | Nucleolin | NA | Treatment | Wu DM et al. FEBS Lett. 2014 |
| 769 | Notch3 | Colon, Rectum | Prognosis | Ozawa T et al. Ann Surg Oncol. 2014 |
| 772 | Protocadherin 10 (PCDH10) | Colon | Prognosis | Jao TM et al. Int J Cancer. 2014 |
| 775 | Sirt7 | NA | Prognosis | Yu H et al. Clin Cancer Res. 2014 |
| 780 | C-reactive protein (CRP) | NA | Prognosis | Shibutani M et al. Surg Today. 2015 |
| 781 | Interleukin-13 (IL-13) | NA | Prognosis | Saigusa S et al. Int Surg. 2014 |
| 782 | RAC1b | NA | Prognosis | Alonso-Espinaco V et al. Eur J Cancer. 2014 |
| 783 | LMO1 | NA | Treatment | Liu J et al. Tumour Biol. 2014 |
| 785 | Tafazzin (TAZ) | Rectum | Prognosis | Pathak S et al. PLoS One. 2014 |
| 786 | CD133 | NA | Prognosis | Pitule P et al. Biomed Res Int. 2014 |
| 787 | CD26 | NA | Prognosis | Lam CS et al. PLoS One. 2014 |
| 789 | Urokinase-type plasminogen activator receptor (uPAR) | NA | Prognosis | Illemann M et al. Cancer Med. 2014 |
| 790 | AMP-activated protein kinase (AMPK) | Colon, Rectum | Prognosis | Zulato E et al. Br J Cancer. 2014 |
| 794 | Vascular endothelial growth factor 1/Fms-like tyrosine kinase 1 (VEGFR1/Flt-1) | Colon, Rectum | Prognosis | Al-Maghrabi J et al. Tumour Biol. 2014 |
| 795 | IL-12p40, IL-23 | Colon, Rectum | Prognosis | Stanilov N et al. APMIS. 2014 |
| 796 | Ephrin type-B receptor 6 (EphB6) | Colon, Rectum | Prognosis | Peng L et al. |
| 800 | Calcium/calmodulin-dependent serine protein kinase (CASK) | NA | Prognosis | Wei JL et al. Tumour Biol. 2014 |
| 802 | Matrix metalloproteinase-7 (MMP-7) | Colon, Rectum | Diagnosis | Keles D et al. Clin Biochem. 2014 |
| 806 | RAGE | NA | Prognosis | Dahlmann M et al. Oncotarget. 2014 |
| 807 | NEDD9 | Colon, Rectum | Prognosis, Treatment | Li P et al. Int J Clin Exp Pathol. 2014 |
| 808 | DEPTOR | Colon, Rectum | Prognosis, Treatment | Lai EY et al. Asian Pac J Cancer Prev. 2014 |
| 809 | Glutathione S-transferase π-1 (GSTP-1) | NA | Treatment | Zhang R et al. Int J Oncol. 2014 |
| 810 | Special AT-rich sequence-binding protein-1 (SATB1) | Rectum | Prognosis, Treatment | Zhang Y et al. PLoS One. 2014 |
| 811 | NLK | Colon, Rectum | Diagnosis, Treatment | Han Y et al. Biomed Pharmacother. 2014 |
| 812 | sphingosine-1-phosphate receptor 1 (S1PR1) | Colon, Rectum | Prognosis | Lin Q et al. Tumour Biol. 2014 |
| 814 | NAT10 (N-acetyltransferase 10) | NA | Prognosis, Treatment | Zhang H et al. Clin Cancer Res. 2014 |
| 816 | ATG4B | NA | Treatment | Liu PF et al. Autophagy. 2014 |
| 817 | YKL-40 | Colon, Rectum | Prognosis | Liu X et al. Med Oncol. 2014 |
| 818 | Podocalyxin | Colon, Rectum | Prognosis | Kaprio T et al. BMC Cancer. 2014 |
| 819 | Protein phosphatase, Mg2+/Mn2+ dependent, 1D (PPM1D) | Colon, Rectum | Prognosis, Treatment | Peng TS et al. Exp Ther Med. 2014 |
| 823 | Carcinoembryonic antigen (CEA), Serum amyloid A (SAA) | Rectum | Prognosis | Giessen C et al. Tumour Biol. 2014 |
| 824 | Zinc-finger protein X-linked (ZFX) | Colon, Rectum | Prognosis | Yan X et al. Int J Clin Exp Pathol. 2014 |
| 828 | DNAJB6 | NA | Prognosis | Zhang TT et al. Mol Carcinog. 2015 |
| 831 | Thomsen-Friedenreich (TF) antigen | NA | Diagnosis | Sakuma S et al. Int J Cancer. 2015 |
| 832 | Bmi1 | NA | Prognosis | Pun JC et al. Mol Clin Oncol. 2014 |
| 833 | Phosphorylated p38 (p-p38) | Colon, Rectum | Prognosis | Fan XJ et al. Tumour Biol. 2014 |
| 835 | Lysine-specific demethylase 1 (LSD1) | NA | Treatment | Hsu HC et al. J Cancer Res Clin Oncol. 2015 |
| 836 | Krppel-like factor 4 (KLF4) | Colon, Rectum | Prognosis | Lee HY et al. World J Surg Oncol. 2014 |
| 837 | Stathmin-1 (STMN1) | NA | Treatment | Wu W et al. Mol Cancer Res. 2014 |
| 838 | FOXC2 | NA | Prognosis | Cui YM et al. Cancer Lett. 2014 |
| 840 | Phosphorylated focal adhesion kinase (P-FAK) | Colon, Rectum | Prognosis | Albasri A et al. Anticancer Res. 2014 |
| 841 | Vimentin methylation | Colon, Rectum | Diagnosis | Shirahata A et al. Anticancer Res. 2014 |
| 843 | A disintegrin, metalloprotease 8 (ADAM8) | Colon, Rectum | Treatment | Yang Z et al. BMC Cancer. 2014 |
| 844 | CDC42 | NA | Prognosis | Sakamori R et al. Cancer Res. 2014 |
| 845 | Melanoma-associated antigen D4 (MAGE-D4) | Colon | Prognosis | Zhang QM et al. Int J Clin Exp Pathol. 2014 |
| 846 | IGFBP3 methylation | Colon, Rectum | Diagnosis, Prognosis | Perez-Carbonell L et al. PLoS One. 2014 |
| 847 | Beclin-1 | NA | Prognosis | Yang Z et al. Clin Res Hepatol Gastroenterol. 2015 |
| 848 | ArhGAP30 | NA | Prognosis | Wang J et al. Nat Commun. 2014 |
| 853 | Interleukin 8 (IL-8) | NA | Prognosis | B?l??oiu M et al. Rom J Morphol Embryol. 2014 |
| 855 | Prothymosin-α (PTMA) | Colon | Prognosis | Zhang M et al. Int J Clin Exp Pathol. 2014 |
| 856 | Ribosomal s6 kinase4 (RSK4) | Colon | Prognosis | Cai J et al. Int J Clin Exp Pathol. 2014 |
| 857 | Uroplakin Ia(UPK la) | Colon | Prognosis | He Y et al. Int J Clin Exp Pathol. 2014 |
| 859 | Polycomb-group (PcG) | Colon, Rectum | Prognosis | Benard A et al. PLoS One. 2014 |
| 862 | Annexin A9 (ANXA9) | Colon | Prognosis | Miyoshi N et al. Oncol Lett. 2014 |
| 863 | β-catenin | Colon, Rectum | Prognosis | Gao ZH et al. Oncol Lett. 2014 |
| 864 | Metastasis-associated in colon cancer-1 (MACC1) | Colon | Prognosis | Yamamoto H et al. Oncol Lett. 2014 |
| 865 | Regenerating islet-derived gene4 (REG4) | Colon, Rectum | Prognosis | Kaprio T et al. PLoS One. 2014 |
| 868 | Ku70, ataxia-telangiectasia mutated (ATM) | Colon | Prognosis | Lu Y et al. Onco Targets Ther. 2014 |
| 869 | Structural maintenance of chromosomes 4 (SMC-4) | Colon | Treatment | Feng XD et al. Asian Pac J Cancer Prev. 2014 |
| 871 | SH2-containing inositol 5'-phosphatase 2 (SHIP2) | Colon, Rectum | Prognosis | Yang J et al. Dis Markers. 2014 |
| 873 | Interleukin-36α (IL-36α) | Colon, Rectum | Prognosis | Wang ZS et al. Int J Clin Exp Pathol. 2014 |
| 874 | Rab27b | Colon, Rectum | Prognosis | Bao J et al. Gastroenterol Res Pract. 2014 |
| 876 | Cryptochrome 2 (CRY2) | NA | Prognosis, Treatment | Fang L et al. Mol Cancer Ther. 2015 |
| 879 | Serine protease inhibitor Kazal-type 1 (SPINK1) | Rectum, Colon | Prognosis | Hu L et al. BMC Cancer. 2015 |
| 880 | Fibulin-1 | >=62 67, <62 66 | Prognosis | Zhu J et al. Am J Transl Res. 2015 |
| 883 | Cancerous inhibitor of protein phosphatase 2A (CIP2A) | Rectum, Colon | Prognosis | Chen KF et al. BMC Cancer. 2015 |
| 885 | Serine protease inhibitor Kazal-type 1 (SPINK1) | Rectum, Colon | Prognosis | Chen YT et al. Pathol Oncol Res. 2015 |
| 886 | RAD54B | Rectum, Colon | Prognosis | Nagai Y et al. Oncotarget. 2015 |
| 891 | Kinesin superfamily protein 2A (KIF2A) | Rectum, Colon | Prognosis | Fan X et al. Tumour Biol. 2015 |
| 892 | Rab27A | Rectum, Colon | Prognosis | Shi C et al. Diagn Pathol. 2015 |
| 893 | Carbonic anhydrase IV (CA4) | Rectum, Colon | Prognosis | Zhang J et al. Gut. 2016 |
| 897 | MYBL2 | Rectum, Colon | Prognosis | Ren F et al. Am J Cancer Res. 2015 |
| 899 | CXCL1 | NA | Prognosis | Ie Rolle AF et al. J Transl Med. 2015 |
| 900 | CD133(+)/ESA(+) cells in MVB | NA | Prognosis | Tseng JY et al. J Surg Res. 2015 |
| 902 | NK2R rs4644560 GC polymorphism | Rectum, Colon | Prognosis | Fang W et al. Oncol Lett. 2015 |
| 904 | RPS24 | NA | Diagnosis, Treatment | Wang Y et al. Gene. 2015 |
| 905 | Lactate dehydrogenase (LDH) | Rectum, Colon | Prognosis | Passardi A et al. PLoS One. 2015 |
| 907 | Dehydrogenase/reductase (SDR family) member 9 (DHRS9) | NA | Prognosis | Hu L et al. Tumour Biol. 2016 |
| 908 | Interferon-induced transmembrane protein 1 (IFITM1) | Rectum, Colon | Prognosis, Treatment | Yu F et al. Cancer Lett. 2015 |
| 909 | 53BP1 | Colon | Prognosis | Bi J et al. Int J Clin Exp Pathol. 2015 |
| 910 | MTA2 | NA | Prognosis, Treatment | Ding W et al. Int J Clin Exp Pathol. 2015 |
| 911 | Twist-related protein 1 (TWIST1) | Rectum, Colon | Prognosis, Treatment | Zhu DJ et al. Am J Cancer Res. 2015 |
| 917 | SDF-1 | NA | Prognosis | Amara S et al. Cancer Biomark. 2015 |
| 918 | CXCR4 | NA | Prognosis | Amara S et al. Cancer Biomark. 2015 |
| 919 | Neuron navigator 2 (NAV2) | Rectum, Colon | Prognosis, Treatment | Tan F et al. J Exp Clin Cancer Res. 2015 |
| 923 | G9a | Colon, Rectum | Treatment | Luo CW et al. Radiother Oncol. 2017 |
| 924 | SHP-1 | Rectum, Colon | Prognosis, Treatment | Fan LC et al. Neoplasia. 2015 |
| 925 | Hexokinase 1 (HK1) | NA | Prognosis | He X et al. Tumour Biol. 2016 |
| 926 | Bone marrow stromal antigen 2 (BST2) | NA | Prognosis | Chiang SF et al.?Dis Markers. 2015 |
| 927 | Growth differentiation factor 15 (GDF15) | Rectum, Colon | Prognosis | Li C et al. Oncotarget. 2016 |
| 928 | Rac GTPase activating protein 1 (RACGAP1) | NA | Prognosis | Yeh CM et al. Hum Pathol. 2016 |
| 930 | Stromal interaction molecule 1 (STIM1) | Rectum, Colon | Treatment | Wong HS et al. Oncotarget. 2015 |
| 931 | NEAT1 | NA | Diagnosis, Prognosis | Wu Y et al. Mol Cancer. 2015 |
| 933 | VE1 antibody | Colon | Prognosis | Hang JF et al. Histopathology. 2016 |
| 937 | Amphiregulin (AR) | NA | Diagnosis | Chen H E et al. J Clin Epidemiol. 2016 |
| 938 | KCTD12 | Rectum, Colon | Prognosis, Treatment | Li L et al. Sci Rep. 2016 |
| 940 | Olfactory receptor family 7 subfamily C member 1 (OR7C1) | Colon | Prognosis | Morita R et al. Clin Cancer Res. 2016 |
| 944 | CXCR3 | Rectum, Colon | Prognosis | Bai M et al.?Mol Clin Oncol. 2016 |
| 945 | 17β-Hydroxysteroid dehydrogenase type 10 (HSD10) | NA | Prognosis | Amberger A et al. Cancer Lett. 2016 |
| 946 | Interferon-induced transmembrane protein 1 (IFITM1) | Rectum, Colon | Prognosis | He J et al. Int J Clin Exp Pathol. 2015 |
| 949 | Excision repair cross-complementation group 1 (ERCC1) | NA | Prognosis | Li MX et al. Chin Med J (Engl). 2016 |
| 950 | Zinc-finger protein X-linked (ZFX) | Rectum, Colon | Prognosis, Treatment | Yan X et al. Oncotarget. 2016 |
| 960 | Human homolog of Drosophila prune protein (h-prune; HGNC13420) | Colon, Rectum | Prognosis | Hashimoto M et al. Int J Cancer. 2016 |
| 961 | h-Prune | Rectum, Colon | Prognosis | Hashimoto M et al. Int J Cancer. 2016 |
| 962 | Myosin VI (MYO6) | NA | Treatment | You W et al. Acta Biochim Biophys Sin (Shanghai). 2016 |
| 963 | Rab3D | Rectum, Colon | Prognosis | Luo Y et al. Int J Biochem Cell Biol. 2016 |
| 964 | Fatty acid-binding proteins 5 (FABP5) | NA | Prognosis, Treatment | Kawaguchi K et al. FEBS Open Bio. 2016 |
| 965 | A-kinase anchor protein (AKAP4) | NA | Diagnosis | Jagadish N et al. Oncoimmunology. 2016 |
| 966 | Anillin (ANLN) | Rectum, Colon | Prognosis | Wang G et al. Cancer Biomark. 2016 |
| 967 | Glutathione S-transferase alpha 4 (GSTA4) | NA | Diagnosis | Yang Y et al. Oncogene. 2016 |
| 970 | combination of CELA1, CTRL | Colon | Diagnosis | Xie Y et al. Oncotarget. 2016 |
| 971 | Combination of CELA1, CTRL | NA | Diagnosis | Xie Y et al. Oncotarget. 2016 |
| 972 | STEAP1 (six transmembrane epithelial antigen of the prostate 1) | NA | Prognosis | Lee CH et al. Int J Mol Sci. 2016 |
| 974 | Serine protease inhibitor Kazal-type 1 (SPINK1) | Rectum, Colon | Prognosis, Treatment | Chen YT et al. J Clin Pathol. 2016 |
| 975 | Pinin (PNN) | NA | Prognosis | Wei Z et al. Oncotarget. 2016 |
| 977 | Cytokeratin 20 (CK20) | Colon, Rectum | Prognosis | Kust D et al. Acta Clin Belg. 2016 |
| 980 | NDUFA4L2 | Rectum, Colon | Prognosis | Lv Y et al. ANZ J Surg. 2016 |
| 981 | Transforming acidic coiled-coil protein-3 (TACC3) | Colon, Rectum | Prognosis | Du Y et al. Oncotarget. 2016 |
| 982 | PDGFR-β | NA | Prognosis | Mezheyeuski A et al. Oncotarget. 2016 |
| 983 | PDGFR-α | NA | Prognosis | Mezheyeuski A et al. Oncotarget. 2016 |
| 986 | S100A4 | Colon, Rectum | Prognosis | Boye K et al. Cancer Med. 2016 |
| 987 | HOTAIRM1 | Colon, Rectum | Diagnosis | Wan L et al.et al. J Cell Mol Med. 2016 |
| 988 | Y-Box-binding protein-1 (YB-1) | NA | Prognosis | Shiraiwa S et al. Anticancer Res. 2016 |
| 989 | Combination of CCR4, TNF-α | Colon, Rectum | Prognosis | Ou B et al. Oncotarget. 2016 |
| 990 | Metalloproteases meprin-α (MEP1A) | Colon, Rectum | Prognosis | Wang X et al. BMC Cancer. 2016 |
| 991 | Carbon atomsC10 | NA | Diagnosis | Crotti S et al. Anal Bioanal Chem. 2016 |
| 992 | Polo-like kinase 2 (Plk2) | NA | Prognosis | Ou B et al. Cancer Lett. 2016 |
| 995 | Syndecan-1 (CD138) | Colon, Rectum | Prognosis | Jary M et al. Int J Cancer. 2016 |
| 996 | Nucleolar protein 66 (NO66) | Colon, Rectum | Prognosis | Nishizawa Y et al. Ann Surg Oncol. 2017 |
| 997 | Nucleolar protein 66 (NO66 [C14orf169/MAPJD]) | Colon, Rectum | Prognosis | Nishizawa Y et al. Ann Surg Oncol. 2017 |
| 1000 | Chemokine (C-C motif) ligand 15 (CCL15) | Colon, Rectum | Prognosis | Yamamoto T et al. Clin Cancer Res. 2017 |
| 1001 | CCL15-CCR1 | Colon, Rectum | Prognosis | Yamamoto T et al. Clin Cancer Res. 2017 |
| 1004 | Dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2) | Colon, Rectum | Prognosis | Yan H et al. PLoS One. 2016 |
| 1005 | SA1 | Colon | Diagnosis | Wali RK et al. Cancer Prev Res (Phila). 2016 |
| 1006 | Olfactomedin 1 (OLFM1) | Colon | Prognosis | Shi W et al. J Pathol. 2016 |
| 1008 | CD51 | Colon | Treatment | Wang J et al. Oncogene. 2017 |
| 1014 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | K?stner AH et al. J Surg Oncol. 2016 |
| 1018 | Interleukin 6 (IL-6) | Colon, Rectum | Prognosis | Thomsen M et al. Oncotarget. 2016 |
| 1019 | C-reactive protein (CRP) | Colon, Rectum | Prognosis | Thomsen M et al. Oncotarget. 2016 |
| 1020 | Cysteine-rich angiogenic inducer 61 (CYR61) | Colon, Rectum | Diagnosis | Song YF et al. Clin Transl Oncol. 2017 |
| 1021 | Cysteine-rich angiogenic inducer 61 (CYR61) | Colon, Rectum | Diagnosis | Song YF et al. Clin Transl Oncol. 2017 |
| 1022 | Thymosin-β4 | Colon | Prognosis | Lee SY et al. J Pathol Transl Med. 2017 |
| 1023 | Thymosin-β4 | Colon, Rectum | Prognosis | Lee SY et al. J Pathol Transl Med. 2017 |
| 1024 | Anti-FIRs (PUF60) | Colon | Diagnosis | Kobayashi S et al. Oncotarget. 2016 |
| 1025 | Trefoil factor 3 | NA | Diagnosis | Li Q et al. Technol Cancer Res Treat. 2016 |
| 1028 | Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) | Colon, Rectum | Prognosis | He X et al. Virchows Arch. 2017 |
| 1029 | Cytoplasmic polyadenylation element-binding protein 4 (CPEB4) | Colon, Rectum | Prognosis | He X et al. Virchows Arch. 2017 |
| 1030 | P-selectin | Colon | Prognosis | Korniluk A et al. Biomarkers. 2016 |
| 1032 | carboxypeptidaseA4 (CPA4) | Colon | Diagnosis | Sun L et al. Oncotarget. 2016 |
| 1033 | carboxypeptidaseA4 (CPA4) | Colon, Rectum | Prognosis | Sun L et al. Oncotarget. 2016 |
| 1034 | MFHAS1 | NA | Prognosis | Chen W et al. Oncotarget. 2016 |
| 1040 | Circulating cellular DCLK1 protein (CCDP) | Colon, Rectum | Prognosis | Mirzaei A et al. Cancer Biomark. 2016 |
| 1041 | ING4 | Colon | Prognosis, Treatment | Chen Y et al. Oncotarget. 2016 |
| 1042 | Interleukin-23 (IL-23) | Colon, Rectum | Prognosis | Hu WH et al. J Surg Oncol. 2017 |
| 1044 | C-reactive protein to albumin (CRP/ALB) | Colon, Rectum | Prognosis | Shibutani M et al. Springerplus. 2016 |
| 1045 | Thymidylate synthase (TS) | Colon, Rectum | Prognosis | Niedzwiecki D et al. Oncologist. 2017 |
| 1046 | Dual specificity phosphatase 5 (DUSP5) | Colon, Rectum | Prognosis | Yan X et al. Am J Cancer Res. 2016 |
| 1047 | Haemoglobin (HbA1c) | Colon, Rectum | Prognosis | Goh SN et al. Int J Colorectal Dis. 2017 |
| 1053 | Aurora kinase A (AURKA) | Colon, Rectum | Prognosis | Koh HM et al. J Pathol Transl Med. 2017 |
| 1057 | Periplakin (PPL) | Colon | Treatment | Li X et al. Biomed Pharmacother. 2017 |
| 1060 | Poly(C)-binding protein 1 (PCBP1) | Colon, Rectum | Treatment | Guo J et al. Oncotarget. 2017 |
| 1061 | Lysosomal acid phosphatase 2(ACP2) | Colon, Rectum | Prognosis | Lee YC et al. Oncotarget. 2017 |
| 1063 | Lactate dehydrogenase (LDH) | Colon, Rectum | Treatment | Marmorino F et al. Br J Cancer. 2017 |
| 1066 | Tumor necrosis factor receptor-associated protein 1 (TRAP1) | Colon, Rectum | Prognosis | Pak MG et al. Diagn Pathol. 2017 |
| 1067 | Histidine triad nucleotide-binding 2 (HINT2) | Colon, Rectum | Prognosis | Li W et al. Oncotarget. 2017 |
| 1071 | Claudin-3 | Colon, Rectum | Diagnosis, Prognosis | Li JY et al. Nan Fang Yi Ke Da Xue Xue Bao. 2017 |
| 1072 | Nm23-H1, p53 | Colon, Rectum | Prognosis | Wu Y et al. Oncol Lett. 2017 |
| 1074 | ADAMTS5 | Colon, Rectum | Prognosis | Haraguchi N et al. Mol Clin Oncol. 2017 |
| 1075 | Hyperplastic polyposis 1 (HPP1) | Colon, Rectum | Prognosis | Herbst A et al. Int J Cancer. 2017 |
| 1076 | Peroxiredoxin 2 (PRDX2) | Colon, Rectum | Prognosis | Peng L et al. Oncotarget. 2017 |
| 1077 | Transducin (β)-like 1 X-linked receptor 1 (TBL1XR1) | Colon, Rectum | Prognosis | Liu H et al. J Gastroenterol Hepatol. 2017 |
| 1079 | EDNRB | Colon, Rectum | Diagnosis | Mousavi Ardehaie R et al. Bioengineered. 2017 |
| 1080 | Kallikrein-related peptidase (KLK) | Colon, Rectum | Prognosis | Liu X et al. Biomed Pharmacother. 2017 |
| 1081 | Enhancer of zeste homolog 2 (EZH2) | Colon, Rectum | Prognosis | Yamamoto I et al. Oncotarget. 2017 |
| 1083 | Acyl-CoA synthetases (ACSL) | Colon, Rectum | Prognosis | Hartmann F et al. Pathol Res Pract. 2017 |
| 1086 | T-cell leukemia/lymphoma-1A (TCL1A) | Colon, Rectum | Prognosis | Li H et al. Biomed Pharmacother. 2017 |
| 1087 | Quaking RNA-binding protein (QKI) | Colon, Rectum | Prognosis | Iwata N et al. Anticancer Res. 2017 |
| 1090 | Programmed death-ligand 1 (PD-L1) | Colon, Rectum | Prognosis | Goltz D et al. Oncoimmunology. 2016 |
| 1091 | Macrophage inhibitory cytokine 1 (MIC-1/GDF15) | Colon, Rectum | Diagnosis, Prognosis | Wang X et al. Oncotarget. 2017 |
| 1092 | Soluble urokinase plasminogen activator receptor (suPAR) | Rectum | Prognosis | Riisbro R et al. Int J Biol Markers. 2005 |
| 1094 | Pituitary tumor transforming gene-1 (PTTG1) | Colon, Rectum | Prognosis | Ren Q et al. Biomed Pharmacother. 2017 |
| 1095 | Tissue transglutaminase (TG2) | Colon | Prognosis | Ayinde O et al. Oncotarget. 2017 |
| 1096 | NM23 | Colon, Rectum | Prognosis | Han W et al. J Huazhong Univ Sci Technolog Med Sci. 2017 |
| 1097 | MLH1 | Colon | Treatment | Hinrichsen I et al. Mol Carcinog. 2017 |
| 1098 | Soluble HLA-G (sHLA-G) | Colon, Rectum | Prognosis | Kirana C et al. Int J Cancer. 2017 |
| 1101 | Vascular endothelial growth factor (VEGF) | Colon, Rectum | Prognosis | Bendardaf R et al. Libyan J Med. 2017 |
| 1106 | Programmed death-ligand 1 (PD-L1) | Colon, Rectum | Prognosis | Koganemaru S et al. Cancer Sci. 2017 |
| 1107 | Fibrinogen | Colon, Rectum | Prognosis | Hong T et al. Cancer Biomark. 2017 |
| 1108 | Phosphorylase kinase β (PHKβ) | Colon, Rectum | Prognosis | Wang G et al. J Cancer Res Clin Oncol. 2017 |
| 1110 | H3.3B | Colon, Rectum | Prognosis | Ayoubi HA et al. J Gastrointest Oncol. 2017 |
| 1112 | Angiopoietin-2 (Ang-2) | Colon, Rectum | Prognosis | Hong S et al. Ann Coloproctol. 2017 |
| 1113 | E-cadherin | Colon, Rectum | Treatment | Christou N et al. J Cancer Res Clin Oncol. 2017 |
| 1114 | Cellular retinol binding protein 1 (CRBP1) | Colon, Rectum | Treatment | Yokoi K et al. Br J Cancer. 2017 |
| 1116 | Apolipoprotein A-I (ApoA-I) | Colon, Rectum | Prognosis | Quan Q et al. Transl Oncol. 2017 |
| 1117 | Matrix Metallopeptidase 9 (MMP-9) | Colon, Rectum | Diagnosis | Lorenc Z et al. Med Sci Monit. 2017 |
| 1118 | Homeobox B9 (HOXB9) | Colon, Rectum | Treatment | Carbone C et al. Clin Cancer Res. 2017 |
| 1121 | Mitogen-, stress-activated protein kinase 1 (MSK1) | Rectum | Prognosis | Fu X et al. Dig Liver Dis. 2017 |
| 1123 | Transducin(β)-like 1 X-linked receptor 1 (TBL1XR1) | Colon, Rectum | Prognosis | Liu H et al. Surg Oncol. 2017 |
| 1124 | Sulfatase-2 (SULF2) | Colon, Rectum | Prognosis | Tao Y et al. Biomed Pharmacother. 2017 |
| 1125 | Semaphorin 3D (SEMA3D) | Colon, Rectum | Diagnosis, Prognosis | Wang Z et al. World J Surg Oncol. 2017 |
| 1126 | DHX32 | Colon, Rectum | Diagnosis, Prognosis | Lin H et al. EBioMedicine. 2017 |
| 1128 | 4E-binding protein 1 (p-4E-BP1) | Colon, Rectum | Prognosis | Miao Y et al. Mol Med Rep. 2017 |
| 1129 | KNG1, OLFM4, Sec24C | Colon, Rectum | Diagnosis | Quesada-Calvo F et al. Clin Proteomics. 2017 |
| 1130 | Mismatch repair genes (MMR) | Colon, Rectum | Prognosis | Li P et al. Cancer Med. 2017 |
| 1132 | Interleukin-6 (IL-6) | Colon, Rectum | Prognosis | Zeng J et al. World J Gastroenterol. 2017 |
812 Biomarker
|
|
All rights reserved: Center for Systems Biology, Soochow University Center for Systems Biology
|